{"study_id": 101365, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to assess the feasibility of a dietary intervention to reduce circulating advanced glycation end-products (AGEs) in older adults with type 2 diabetes and its impact on serum AGE levels.", "results_summary": "The intervention significantly reduced several serum AGEs compared to standard care, with high adherence (above 80%) leading to greater reductions. No significant differences were found in other metabolic markers between the intervention and control groups.", "population_specificity": "Older adults with type 2 diabetes.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:37:24.098905+00:00"}
{"study_id": 101369, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 75, "study_goal": "The researchers aimed to explore the role of Advanced Glycation End Products (AGEs) in the pathogenesis of polycystic ovary syndrome (PCOS) and discuss potential molecular-level drug targets for treatment.", "results_summary": "The study found that elevated levels of AGEs in ovaries contribute to PCOS-related disruptions, including anovulation, and highlighted molecular malfunctions (e.g., altered enzyme activities) as key factors in PCOS development.", "population_specificity": "Females with polycystic ovary syndrome (PCOS).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:37:24.267585+00:00"}
{"study_id": 101367, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 75, "study_goal": "The researchers aimed to explore the role of Advanced Glycation End Products (AGEs) in the pathogenesis of diabetes-induced cognitive impairment (DCI) and their interaction with VEGF spatiotemporal variations.", "results_summary": "The study found that AGEs, along with hyperglycemia and abnormal brain insulin signals, contribute to hypoxia, oxidative stress, and inflammation in DCI, influencing VEGF-mediated pathological changes such as cerebral neovascularization and BBB permeability.", "population_specificity": "Patients with diabetes and associated cognitive impairment.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:37:24.479544+00:00"}
{"study_id": 101368, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 75, "study_goal": "The researchers aimed to explore how advanced glycation end products (AGEs) may contribute to the severity of COVID-19 in individuals with obesity and diabetes.", "results_summary": "The study suggests that AGEs, along with other metabolic factors, may exacerbate the inflammatory response to SARS-CoV-2 infection, potentially leading to severe outcomes like cytokine storms and multi-organ failure. It highlights the chronic activation of these mechanisms in metabolic diseases as a possible facilitator of more profound viral infections.", "population_specificity": "Individuals with obesity and diabetes.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:37:24.858273+00:00"}
{"study_id": 101370, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to review current methodologies for detecting Advanced Glycation End Products (AGEs) and explore their potential mechanisms in causing or exacerbating musculoskeletal disorders.", "results_summary": "The study found that AGEs accumulate in neuromusculoskeletal tissues, adversely affecting biomechanical properties and inducing inflammation, leading to conditions like osteoporosis, osteoarthritis, sarcopenia, tendinopathy, and neuropathy. The formation of AGEs is irreversible, and their detection lacks standardized methods due to heterogeneity.", "population_specificity": "Elderly and diabetic patients with musculoskeletal disorders.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:37:29.227908+00:00"}
{"study_id": 101371, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to review the relationship between oxidative stress, including advanced glycation end products, and autoimmune thyroiditis.", "results_summary": "The study found that oxidative stress is a key feature of autoimmune thyroiditis, with an imbalance between oxidants and antioxidants contributing to disease progression. Advanced glycation end products were included as part of the oxidative stress biomarkers evaluated.", "population_specificity": "Patients with autoimmune thyroiditis and animal models (e.g., NOD.H2h4 mice).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:37:29.584271+00:00"}
{"study_id": 101372, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 75, "study_goal": "The researchers aimed to explore the potential interplay between estrogen receptors (ERs), RAGE (receptor for advanced glycation end-products), and COVID-19 mortality rates, despite a lack of direct research on this relationship.", "results_summary": "The abstract does not present specific findings on Advanced Glycation End Products (AGEs) but suggests a potential link between RAGE, metabolic pathways, and COVID-19 mortality, highlighting a need for further research.", "population_specificity": "Elderly population with preexisting pathologies, particularly focusing on gender differences in SARS-CoV-2 infection.", "effective_dosage": "Not available", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:37:31.090955+00:00"}
{"study_id": 101376, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to review the therapeutic potential of flavonoids in managing diabetic neuropathy, including their role in inhibiting the formation of Advanced Glycation End Products (AGEs).", "results_summary": "Flavonoids were found to inhibit pathways involved in diabetic neuropathy progression, including reducing oxidative stress and decreasing AGE formation. Preclinical studies suggest flavonoids may ameliorate neuropathic pain, either alone or in combination with other agents.", "population_specificity": "Preclinical studies (not specified if human or animal models).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:37:32.114139+00:00"}
{"study_id": 101377, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 65, "study_goal": "The researchers aimed to explore the role of Advanced Glycation End Products (AGEs) in atherosclerosis development and evaluate plant-based bioactive compounds as potential therapeutic interventions.", "results_summary": "The study highlights that AGE-RAGE interactions and related pathways contribute to oxidative stress and atherosclerosis progression. It suggests that plant-based bioactive compounds, particularly alkaloids and flavonoids, may offer safer and effective alternatives for treatment.", "population_specificity": "Diabetic patients at risk of atherosclerosis.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:37:32.232733+00:00"}
{"study_id": 101373, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": 20, "quality_score": 85, "study_goal": "The researchers aimed to determine whether irbesartan (an ARB) could lower plasma levels of dicarbonyls (methylglyoxal, glyoxal, 3-deoxyglucosone) and their derived AGEs in individuals with type 2 diabetes.", "results_summary": "The study found no significant changes in plasma dicarbonyls, free AGEs, or d-lactate levels after 1 or 2 years of irbesartan treatment, indicating ARBs do not effectively target dicarbonyls in type 2 diabetes.", "population_specificity": "Individuals with type 2 diabetes and microalbuminuria.", "effective_dosage": "300 mg irbesartan daily.", "study_duration": "2 years.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:37:32.378894+00:00"}
{"study_id": 101374, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to summarize the role of ncRNAs in regulating AGE/RAGE signaling-mediated ER stress and discuss the potential of ncRNA-loaded extracellular vesicle therapy for diabetic nephropathy.", "results_summary": "The study found that AGEs contribute to ER stress, inflammation, and renal damage in diabetic nephropathy, and that ncRNAs may rescue ER stress and inflammation through epigenetic modification. It highlights the therapeutic potential of ncRNA-loaded extracellular vesicles but notes challenges in their application.", "population_specificity": "Diabetic nephropathy (specific human population not detailed in abstract).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:37:32.776641+00:00"}
{"study_id": 101375, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": 30, "quality_score": 65, "study_goal": "The researchers aimed to determine if serum sRAGE levels could predict severity and prognosis in infants with severe acute bronchiolitis (AB).", "results_summary": "The study found no significant correlation between serum sRAGE levels and AB severity, clinical symptoms, or outcomes. However, sRAGE levels were higher in patients with lung consolidation and weakly correlated with classical biomarkers like C-reactive protein and procalcitonin.", "population_specificity": "Hospitalized infants (11 days to 21 months old) with severe bronchiolitis admitted to the Pediatric Intensive Care Unit (PICU).", "effective_dosage": "Not specified", "study_duration": "Observational period from September 2015 to September 2016 (exact intervention duration not specified).", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:37:33.633860+00:00"}
{"study_id": 101378, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to determine whether casein hydrolysate reduces facial pigmentation in nonhypertensive individuals by decreasing skin accumulation of advanced glycation end products (AGEs).", "results_summary": "Casein hydrolysate significantly reduced facial pigmentation area and triglycerides, with positive associations between changes in AGEs and pigmentation. It also improved arterial stiffness (baPWV), though this was not directly linked to pigmentation changes.", "population_specificity": "80 nonhypertensive Japanese patients", "effective_dosage": "Not specified", "study_duration": "48 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:37:36.836546+00:00"}
{"study_id": 101379, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to summarize the role of AMPK in regulating cardio-metabolic abnormalities, including the accumulation of Advanced Glycation End Products, during the development of diabetic cardiomyopathy.", "results_summary": "The study highlights the beneficial role of AMPK in mitigating various cardio-metabolic abnormalities, including the accumulation of Advanced Glycation End Products, but does not provide specific efficacy data for Advanced Glycation End Products themselves.", "population_specificity": "Patients with diabetic cardiomyopathy, particularly those with metabolic abnormalities.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:37:37.129737+00:00"}
{"study_id": 101381, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 70, "study_goal": "The researchers aimed to determine the association between skin advanced glycation end-products (AGEs) and microvascular health in patients with COPD.", "results_summary": "The study found that skin AGEs, measured via autofluorescence, were independently associated with retinal arteriolar and venular vessel diameters, indicating a link between AGEs and microvascular health in COPD patients.", "population_specificity": "62 patients with COPD (52% male, mean age 64.4 \u00b1 8.4 years).", "effective_dosage": "Not specified", "study_duration": "Not specified (cross-sectional study)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:37:40.074585+00:00"}
{"study_id": 101383, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 75, "study_goal": "The researchers aimed to review the role of Advanced Glycation End Products (AGEs) in blood-retinal barrier dysfunction and diabetic retinopathy.", "results_summary": "The abstract highlights that AGEs contribute to blood-retinal barrier dysfunction in diabetic retinopathy, alongside other mechanisms like oxidative stress and vascular endothelial growth factor, but does not provide specific efficacy or safety data on AGEs.", "population_specificity": "Diabetic retinopathy patients (theoretical, as this is a review article).", "effective_dosage": "Not available", "study_duration": "Not applicable (review article)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:37:40.523599+00:00"}
{"study_id": 101384, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the role of advanced glycation end-products (AGEs) in the pathophysiology of acute Charcot neuroarthropathy (ACN) and identify potential therapeutic pathways.", "results_summary": "The study highlighted the interplay between AGEs, neuropeptides, monocyte differentiation, and genomics in ACN, suggesting these factors contribute to the disease's pathophysiology and may inform future treatments.", "population_specificity": "Patients with diabetes and peripheral neuropathy, specifically those with acute Charcot neuroarthropathy in the foot and ankle.", "effective_dosage": "Not available", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:37:40.652501+00:00"}
{"study_id": 101385, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 75, "study_goal": "The researchers aimed to summarize the role of S100B in neurological disorders and explore potential therapeutic measures to reduce their prevalence, focusing on its interaction with Advanced Glycation End Products (AGE).", "results_summary": "The abstract highlights that S100B, through AGE binding, mediates both toxic effects under stress and neuroprotective effects, depending on concentration. Elevated S100B levels are linked to neuroinflammation and neuronal loss in various neurological disorders.", "population_specificity": "Not specified (general neurological disorder context).", "effective_dosage": "Not mentioned.", "study_duration": "Not mentioned.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:37:41.371684+00:00"}
{"study_id": 101382, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to explore the role of Advanced Glycation End Products (AGEs) in cardiovascular complications in diabetes and assess potential therapeutic interventions targeting AGE/RAGE interactions.", "results_summary": "The study found that AGEs contribute to inflammation, oxidative stress, and calcium homeostasis disruption in cardiac cells of diabetic patients, implicating the AGE/RAGE axis in cardiovascular complications. Promising therapeutic results from nutraceutical, pharmaceutical, and natural product interventions were noted.", "population_specificity": "Diabetic patients with cardiovascular complications.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:37:41.646839+00:00"}
{"study_id": 101387, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 75, "study_goal": "The researchers aimed to explore the role of dysregulated autophagy in diabetic kidney disease and its potential as a therapeutic target.", "results_summary": "The abstract suggests that dysregulated autophagy contributes to kidney pathologies in diabetic conditions, highlighting its potential as a new therapeutic target for diabetic kidney disease.", "population_specificity": "Individuals with diabetic kidney disease (general, not specified further).", "effective_dosage": "Not available", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:37:43.776979+00:00"}
{"study_id": 101386, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 65, "study_goal": "The researchers aimed to review the protective mechanisms of phytoagents against diabetic nephropathy, focusing on their ability to counteract advanced glycation end-products and related pathways.", "results_summary": "The study highlights that phytoagents can mitigate diabetic nephropathy by enhancing antioxidant capabilities, reducing inflammation, and inhibiting fibrosing pathways, particularly those involving TGF-\u03b2.", "population_specificity": "Not specified (review paper, not a clinical study).", "effective_dosage": "Not specified.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:37:44.268577+00:00"}
{"study_id": 101388, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to explore the role of Advanced Glycation End Products (AGEs) in the increased tissue stiffness observed in glaucoma, particularly in the lamina cribrosa.", "results_summary": "The study suggests that AGEs, along with other cross-linking proteins like LOX and TG2, may contribute to tissue stiffening in glaucoma, supported by elevated mRNA levels of these proteins in glaucoma LC cells. The findings highlight the potential role of AGEs in glaucoma pathogenesis but do not establish a direct therapeutic effect.", "population_specificity": "The study focuses on glaucoma patients, specifically examining lamina cribrosa cells.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:37:48.125242+00:00"}
{"study_id": 101390, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to explore the interaction between AGEs and RAGE, their associated signaling pathways, and the potential of phytochemicals to block AGE formation and RAGE interaction.", "results_summary": "The study highlights that AGE-RAGE interaction activates pathways like NF-\u03baB and PI3K/Akt, contributing to diabetes and cancers. Phytochemicals like genistein and curcumin may inhibit AGE formation by trapping dicarbonyl compounds.", "population_specificity": "Not specified (review article)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:37:48.405997+00:00"}
{"study_id": 101389, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 70, "study_goal": "The researchers aimed to explore the role of D-galactose in skin aging and its relationship with oxidative stress, focusing on the production of Advanced Glycation End Products (AGEs).", "results_summary": "The abstract suggests that dietary carbohydrates, particularly glucose and galactose, contribute to skin aging through nonenzymatic glycation and AGE formation, linking this process to oxidative stress. However, specific outcomes or clinical effects are not detailed.", "population_specificity": "Not specified (general discussion on skin aging mechanisms).", "effective_dosage": "Not available", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:37:48.779323+00:00"}
{"study_id": 101391, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to compare skin autofluorescence (SAF) levels, a measure of advanced glycation end products (AGEs) accumulation, between diabetic and non-diabetic dialysis patients.", "results_summary": "Dialysis patients with diabetes had significantly higher SAF levels than non-diabetic dialysis patients, indicating greater AGEs accumulation. The difference was more pronounced in hemodialysis patients, and the findings support considering anti-AGE therapeutic strategies for diabetic dialysis patients.", "population_specificity": "Diabetic and non-diabetic dialysis patients (hemodialysis and other modalities).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:37:50.032631+00:00"}
{"study_id": 101392, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to explore the role of HMGB1-induced neuroinflammation in brain injuries and its interaction with RAGE (receptor for advanced glycation end products), TLR4, and other inflammatory mediators.", "results_summary": "The study found that HMGB1 plays a key role in neuroinflammation during brain injuries like TBI and EBI after SAH, mediated through RAGE and TLR4. Inhibition or neutralization of HMGB1 showed promising neuroprotective effects in these conditions.", "population_specificity": "Individuals with traumatic brain injury (TBI) or early brain injury (EBI) after subarachnoid hemorrhage (SAH).", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:37:50.814473+00:00"}
{"study_id": 101393, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": 45, "quality_score": 75, "study_goal": "The researchers aimed to explore the role of Advanced Glycation End Products (AGEs) in autophagic stress and lysosomal dysfunction in diabetic kidney disease (DKD).", "results_summary": "The study suggests that AGEs contribute to autophagic stress and lysosomal dysfunction in DKD, potentially leading to renal cytotoxicity. Therapeutic interventions targeting lysosomal restoration may mitigate these effects.", "population_specificity": "Diabetic kidney disease (DKD) patients and animal/human renal cells under hyperglycemic conditions.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:37:51.308272+00:00"}
{"study_id": 101394, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to explore the role of the ERK5-Nrf2 pathway in reducing harmful advanced glycation end-products (AGE) in vascular smooth muscle cells (VSMCs) during diabetic vasculopathy.", "results_summary": "The study identified the ERK5-Nrf2 pathway as a mechanism that reduces AGE levels in VSMCs, suggesting potential therapeutic benefits for diabetic vasculopathy. The review also highlighted other promising targets like microRNA-based therapies for eNOS regulation.", "population_specificity": "Patients with atherosclerotic lesions and diabetic vasculopathy (implied by focus on VSMCs and AGE).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:37:52.387193+00:00"}
{"study_id": 101395, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 85, "study_goal": "The researchers aimed to understand the molecular mechanisms by which Advanced Glycation End Products (AGEs) contribute to vascular complications in diabetes mellitus.", "results_summary": "The abstract highlights that AGEs are part of a biochemical pathway activated by hyperglycemia, leading to vascular endothelial dysfunction and complications in diabetes, but does not provide specific results on AGEs' effects.", "population_specificity": "Individuals with diabetes mellitus (general, not specified further).", "effective_dosage": "Not available", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:37:55.339085+00:00"}
{"study_id": 101396, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to explore the role of HMGB1 signaling and its interaction with RAGE and TLR4 in promoting inflammation in the diabetic retina.", "results_summary": "The study found that HMGB1, RAGE, and TLR4 pathways contribute to retinal inflammation in diabetic retinopathy, and inhibiting these pathways may offer therapeutic potential.", "population_specificity": "Patients with late-stage diabetic retinopathy and diabetic animal models.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:37:55.676646+00:00"}
{"study_id": 101397, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 65, "study_goal": "The researchers aimed to explore the role of Advanced Glycation End Products (AGEs) as potential contributors to vascular calcification in chronic kidney disease (CKD).", "results_summary": "The abstract suggests that AGEs, along with other uremic toxins, may contribute to vascular calcification in CKD, but no specific results on AGEs' effects are detailed.", "population_specificity": "Chronic kidney disease (CKD) patients", "effective_dosage": "Not available", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:37:56.209059+00:00"}
{"study_id": 101398, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 65, "study_goal": "The researchers aimed to review the generation process, mechanisms, pathological significance of AGEs, and novel treatments targeting AGEs for infertility.", "results_summary": "The study found that AGEs are associated with senescence, diabetes, vascular disease, aging, kidney disease, and infertility-related diseases, highlighting their crucial role in pathogenesis. The review also discusses potential treatments targeting AGEs for infertility.", "population_specificity": "Couples of reproductive ages affected by infertility (approximately 10-15%).", "effective_dosage": "Not available", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:37:56.931569+00:00"}
{"study_id": 101399, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to identify biomarkers, including receptor for advanced glycation end products (RAGE), associated with ARDS development or mortality in critically ill patients.", "results_summary": "High plasma levels of RAGE were associated with an increased risk of ARDS development, but RAGE did not independently predict ARDS mortality.", "population_specificity": "Critically ill patients at risk for ARDS or with ARDS (10,667 patients at risk for ARDS and 15,344 patients with ARDS).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:37:58.004654+00:00"}
{"study_id": 101400, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to explore the role of NOX and its associated pathways, including Advanced Glycation End Products, in the development and management of diabetic complications.", "results_summary": "The study found that overexpression of NOX, linked to Advanced Glycation End Products, contributes to diabetic complications by promoting oxidative stress, inflammation, and vascular damage. NOX inhibitors were highlighted as potential therapeutic targets for managing these complications.", "population_specificity": "Individuals with diabetes and associated complications (e.g., nephropathy, retinopathy, neuropathy, cardiomyopathy).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:37:58.943324+00:00"}
{"study_id": 101380, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to explore the role of Advanced Glycation End Products (AGEs) in renal accelerated aging under diabetes mellitus conditions and potential antiaging interventions.", "results_summary": "The study found that AGEs contribute to renal aging in diabetes, alongside other stresses like oxidative stress and inflammation. Antiaging interventions, including autophagy-lysosome system modulation and dietary changes, were suggested but require further long-term study.", "population_specificity": "Elderly patients with aging-related diabetic nephropathy (DN).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:37:59.824920+00:00"}
{"study_id": 101401, "supplement_id": 857, "safety_score": "85", "efficacy_score": 60, "quality_score": 75, "study_goal": "The researchers aimed to investigate the association between oral glucose tolerance tests (OGTT) and changes in maternal symptoms, blood nonenzymatic advanced glycation end products (AGE), inflammatory markers, and oxidative stress.", "results_summary": "The study found that OGTT did not significantly alter AGE, sRAGE, or TRAP levels, but increased serum CRP without affecting IL-6. The screening tools for gestational diabetes were deemed safe and well-tolerated.", "population_specificity": "Second-trimester pregnant women screened for gestational diabetes mellitus (GDM).", "effective_dosage": "50 g OGTT or water (nonfasting); 100 g OGTT (fasting).", "study_duration": "Not specified in the abstract.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:38:01.485189+00:00"}
{"study_id": 101402, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 75, "study_goal": "The researchers sought to summarize the effects of vitamin D on Advanced Glycation End Products (AGEs) and their receptors (RAGE and sRAGE).", "results_summary": "Vitamin D treatment may reduce AGE levels and increase sRAGE levels, particularly in vitamin D-deficient situations, but its effect on RAGE expression varies by disease condition. The effects are mediated by signaling pathways like MAPK/NF-\u03baB, ADAM10/MMP9, and AT1R.", "population_specificity": "Populations with chronic diseases and concomitant hypovitaminosis D.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:38:03.132489+00:00"}
{"study_id": 101403, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to explore the role of inflammation, including the impact of advanced glycation end-products (AGEs), on muscle loss in osteoarthritis (OA), chronic obstructive pulmonary disease (COPD), and type II diabetes (T2D).", "results_summary": "The study found that AGEs and reduced mTORC1 activation contribute to muscle atrophy in T2D rodent models, but the connection in human patients remains unclear. Associations between inflammation and muscle loss were inconsistent across OA, COPD, and T2D, with a need for more longitudinal research.", "population_specificity": "Rodent models and human patients with OA, COPD, and T2D.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:38:04.064733+00:00"}
{"study_id": 101404, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to review the role of the glyoxalase (GLO) pathway in mitigating advanced glycation end products (AGEs) and explore its potential as a therapeutic target for age-related diseases.", "results_summary": "The study found that AGEs accumulate in pathological and physiological conditions, contributing to diseases like diabetes, Alzheimer's, and aging. Glyoxalase-1 (GLO-1) plays a critical role in detoxifying AGE precursors, suggesting modulation of the GLO pathway could be a therapeutic strategy.", "population_specificity": "Not specified (review of existing literature).", "effective_dosage": "Not specified.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:38:04.205400+00:00"}
{"study_id": 101405, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 75, "study_goal": "The researchers aimed to discuss the factors and mechanisms affecting the integrity of Bruch's membrane to aid in developing effective therapies for pathologies like age-related macular degeneration.", "results_summary": "The abstract highlights the underrated role of Bruch's membrane dysfunction in ocular diseases, emphasizing the need to address extracellular matrix degeneration alongside cellular components for optimal clinical benefit.", "population_specificity": "Not specified (focus on Bruch's membrane pathology in general, not a specific human or animal population).", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:38:04.318120+00:00"}
{"study_id": 101407, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to investigate the role of HMGB1 and its receptors (RAGE and TLR4) in ALS pathogenesis and explore therapeutic outcomes of inhibiting HMGB1 receptor signaling.", "results_summary": "The study found that HMGB1, RAGE, and TLR4 signaling pathways may contribute to ALS pathogenesis, and inhibiting these pathways could prevent motor neuron death and delay disease progression in experimental models.", "population_specificity": "Pre-clinical experimental models (not human subjects).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:38:06.417927+00:00"}
{"study_id": 101408, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": null, "study_goal": "The researchers were attempting to explore the endocrine functions of bone beyond mineral metabolism, such as its role in insulin sensitivity, glucose homeostasis, and energy metabolism.", "results_summary": "The abstract mentions the discovery of multiple endocrine functions of bone related to insulin sensitivity, glucose homeostasis, and energy metabolism, but does not provide specific findings on Advanced Glycation End Products.", "population_specificity": "Not specified", "effective_dosage": "Not available", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:38:06.774162+00:00"}
{"study_id": 101406, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the role of HMGB1-mediated brain damage in aneurysmal subarachnoid hemorrhage (aSAH) and the potential of pharmacological interventions targeting HMGB1, including soluble receptors for advanced glycation end products (sRAGE), to mitigate inflammation and cerebral vasospasm.", "results_summary": "The study found that HMGB1 contributes to brain damage and cerebral vasospasm post-aSAH, and pharmacological interventions like sRAGE, which scavenges HMGB1, showed promise in reducing inflammation-mediated damage and protecting against vasospasm in experimental models.", "population_specificity": "The study focused on experimental models and literature related to aneurysmal subarachnoid hemorrhage (aSAH) patients.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:38:06.901077+00:00"}
{"study_id": 101412, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": null, "study_goal": "The researchers aimed to assign and quantify N in relation to Advanced Glycation End Products (AGEs).", "results_summary": "The abstract does not provide specific findings regarding AGEs' effects.", "population_specificity": "Not specified.", "effective_dosage": "Not provided.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:38:10.430859+00:00"}
{"study_id": 101409, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to investigate the effects of Exo-d-MAPPS, which contains soluble receptor for advanced glycation end products, in attenuating chronic airway inflammation in COPD using animal models and clinical data.", "results_summary": "Exo-d-MAPPS significantly improved respiratory function and reduced serum levels of inflammatory cytokines in COPD models and patients, suggesting its potential in mitigating chronic airway inflammation.", "population_specificity": "Animal models of COPD (induced by cigarette smoke) and Exo-d-MAPPS-treated COPD patients.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:38:11.144175+00:00"}
{"study_id": 101411, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the role of alarmins, including those acting through RAGE (receptor for advanced glycation end products), in osteoporosis.", "results_summary": "The study highlights the emerging roles of alarmins in bone remodeling processes linked to osteoporosis and suggests their potential as biomarkers and pharmacological targets for preventing bone loss and fragility fractures.", "population_specificity": "Not specified (general focus on osteoporosis and inflammatory diseases).", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:38:11.528090+00:00"}
{"study_id": 101413, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 65, "study_goal": "The researchers aimed to evaluate the scientific literature to identify the impacts of resveratrol on the accumulation of Advanced Glycation End Products (AGEs).", "results_summary": "The review found that resveratrol showed inhibitory effects on AGE accumulation or its receptors in most studies, suggesting it may be a protective agent against AGE-related complications. However, the majority of studies were conducted on animals, with only one clinical trial included.", "population_specificity": "Primarily animal studies, with one clinical trial involving humans.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:38:11.653341+00:00"}
{"study_id": 101410, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 75, "study_goal": "The researchers aimed to review and update the most common methods for determining Advanced Glycation End Products (AGEs) in biological samples and describe their signaling mechanisms and epigenetic effects.", "results_summary": "The abstract highlights the heterogeneity of AGEs and the lack of a specific test for their measurement. It reviews various analytical methods, emphasizing the promise of mass spectrometry for early diagnosis and therapeutics, despite its complexity, and notes the simplicity but lower precision of immunochemical tests.", "population_specificity": "Not specified (review of methods and mechanisms).", "effective_dosage": "Not available", "study_duration": "Not applicable", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:38:11.854685+00:00"}
{"study_id": 101415, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to investigate the association between metabolic syndrome (MetS) and osteoarthritis (OA), focusing on the role of leptin and the impact of advanced glycation end-products (AGEs) in OA pathogenesis.", "results_summary": "The study found that hyperglycemia-induced advanced glycation end-products contribute to OA pathophysiology through oxidative stress and inflammation. Elevated leptin levels were associated with OA progression, suggesting a potential role in metabolic-associated OA.", "population_specificity": "Primarily the Asian population, with additional insights from animal studies.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:38:15.777687+00:00"}
{"study_id": 101414, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 85, "study_goal": "The researchers aimed to explore how targeting the receptor for advanced glycation end products (RAGE) might prevent the development of Type 1 diabetes (T1D).", "results_summary": "The abstract highlights that prolonged hyperglycemia in T1D upregulates RAGE and accelerates the formation of RAGE ligands, which are implicated in chronic inflammation and disease progression. Changes in RAGE and its ligands are evident even before T1D onset, suggesting RAGE as a potential therapeutic target.", "population_specificity": "Patients with or at risk of Type 1 diabetes.", "effective_dosage": "Not available", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:38:16.007231+00:00"}
{"study_id": 101416, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to investigate the role of HMGB1, RAGE, and TLR4 signaling in neuroinflammation and Alzheimer's disease (AD) pathogenesis, and assess the therapeutic potential of targeting these pathways.", "results_summary": "Targeting HMGB1, RAGE, and TLR4 in experimental AD models showed beneficial effects, including reduced neuroinflammation, decreased A\u03b2 load, improved spatial learning, and inhibited microglial stimulation. These findings suggest potential therapeutic benefits for AD progression.", "population_specificity": "Experimental AD models (not specified if human or animal, but likely animal models based on context).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:38:16.066177+00:00"}
{"study_id": 101417, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 65, "study_goal": "The researchers aimed to determine whether correcting malnutrition in dialysis patients could stabilize skin autofluorescence (SAF), a marker of AGE accumulation, despite increased dietary AGE intake.", "results_summary": "The intervention group showed improved nutritional markers and stable SAF levels over 6 months, while the control group experienced a significant increase in SAF without nutritional improvement, suggesting dietetic support may prevent SAF rise in malnourished dialysis patients.", "population_specificity": "Patients on hemodialysis (n=27) or peritoneal dialysis (n=1) with malnutrition, compared to a control group of malnourished dialysis patients (n=41 HD, 8 PD).", "effective_dosage": "Not specified", "study_duration": "6 months", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:38:21.042643+00:00"}
{"study_id": 101420, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to review the role of Advanced Glycation End Products (AGEs) in the pathophysiology of glucose and lipid metabolism, particularly in diabetes and atherosclerosis.", "results_summary": "The study found that AGEs may contribute to the initial pathogenesis of diabetes and atherosclerosis, with AGE precursors and receptors linked to insulin resistance and lipid metabolism disorders. Emerging therapeutic interventions targeting AGE reduction and AGE-RAGE signaling showed some beneficial clinical outcomes.", "population_specificity": "Animal models (specific human population not mentioned).", "effective_dosage": "Not specified.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:38:21.269220+00:00"}
{"study_id": 101418, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to explore the role of receptors for advanced glycation end products (RAGE) in neuroinflammation and brain injury following subarachnoid hemorrhage (SAH).", "results_summary": "The study found that RAGE, along with other pattern recognition receptors, activates inflammatory pathways contributing to brain injury in SAH. It also highlighted matricellular proteins (MCPs) as potential therapeutic targets and biomarkers for neuroinflammation in SAH.", "population_specificity": "Pre-clinical models and theoretical clinical settings related to subarachnoid hemorrhage.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:38:21.460516+00:00"}
{"study_id": 101421, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 80, "study_goal": "The researchers aimed to compare serum AGEs levels and subclinical atherosclerotic markers between patients with established and newly diagnosed T2DM.", "results_summary": "The study found that AGEs levels (methylglyoxal and N-carboxymethyl lysine) were measured alongside subclinical atherosclerotic markers (brachial flow-mediated vasodilation and carotid intima-media thickness) in T2DM patients, but specific comparative results were not detailed in the abstract.", "population_specificity": "540 patients with T2DM and coronary heart disease (350 with established T2DM, 190 with newly diagnosed T2DM).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:38:22.569943+00:00"}
{"study_id": 101419, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to evaluate the efficacy and safety of Shen-Qi Hua-Yu formula (a Chinese herbal medicine) in treating diabetic lower extremity artery disease (LEAD) and explore its mechanism of action, including the role of advanced glycation end products (AGEs).", "results_summary": "The study protocol outlines plans to measure AGEs as a secondary outcome, but no results are provided in the abstract. The trial will assess AGEs alongside other biomarkers to evaluate the formula's efficacy and therapeutic mechanism.", "population_specificity": "Type 2 Diabetes Mellitus patients with lower extremity artery disease (LEAD).", "effective_dosage": "Not specified in the abstract.", "study_duration": "12-week treatment with a 48-week follow-up.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:38:22.616820+00:00"}
{"study_id": 101422, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to investigate the role of AGE, RAGE, and AGE-RAGE stress in the pathogenesis of abdominal and thoracic aortic aneurysms in humans.", "results_summary": "Elevated levels of AGE, RAGE, and AGE-RAGE stress, along with reduced sRAGE, were linked to increased cytokines and Matrix metalloproteinases, contributing to aortic aneurysm formation. The study suggests AGE-RAGE stress plays a key role in aneurysm pathogenesis.", "population_specificity": "Patients with thoracic aortic aneurysm and abdominal aortic aneurysm.", "effective_dosage": "Not available", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:38:25.010844+00:00"}
{"study_id": 101424, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to explore the relationship between oxidative stress, advanced glycation end products (AGEs), and their role in diabetic cardiovascular complications.", "results_summary": "The study highlights that AGEs and their receptor interactions (RAGEs) are a common upstream pathway in oxidative stress under diabetic conditions, contributing to cardiovascular complications. It emphasizes the significance of understanding this relationship for prevention and treatment strategies.", "population_specificity": "Patients with diabetes, particularly those at risk of cardiovascular complications.", "effective_dosage": "Not available", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:38:25.276363+00:00"}
{"study_id": 101423, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to identify which oxidative stress markers, including advanced glycation end products, are associated with prostate cancer progression.", "results_summary": "The study found that men with prostate cancer who had undergone prostatectomy had 20% higher levels of carboxymethyllysine (a marker for advanced glycation end products) compared to men with benign prostatic hyperplasia, though this difference was not statistically significant (P = .08). Different oxidation markers showed varying associations with PSA elevation, suggesting complex roles in prostate cancer progression.", "population_specificity": "Men with prostate cancer (post-prostatectomy or under watchful waiting) and men with benign prostatic hyperplasia.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:38:26.352310+00:00"}
{"study_id": 101425, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to explore the biological mechanisms and clinical relevance of advanced glycation end products in cardiovascular disease development, particularly focusing on vascular calcification.", "results_summary": "The study found that advanced glycation end products are strongly associated with cardiovascular disease in kidney failure patients, contributing to pathways like inflammation, fibrosis, and vascular calcification. These modifications are not merely incidental but play a significant role in disease progression.", "population_specificity": "Patients with kidney failure", "effective_dosage": "Not available", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:38:28.169283+00:00"}
{"study_id": 101427, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 65, "study_goal": "The researchers aimed to evaluate the therapeutic effects of propolis extracts on metabolic disorders, including the modulation of advanced glycation end products (AGEs), oxidative stress, and adipose tissue inflammation.", "results_summary": "Propolis extracts showed potential therapeutic effects on obesity and metabolic disorders by controlling adipogenesis, adipokine secretion, and energy expenditure, while also modulating AGE accumulation and oxidative stress, which may mitigate diabetic complications.", "population_specificity": "Animal models (mice and rats) and cellular models.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:38:29.092196+00:00"}
{"study_id": 101428, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to summarize the roles of S100 proteins (S100A8, S100A9, S100A12) in vascular inflammation, calcification, and oxidative stress, and their interaction with Advanced Glycation End Products (RAGE) in atherosclerosis.", "results_summary": "The study found that S100 proteins binding to RAGE activate downstream signaling (e.g., NF-\u03baB translocation, ROS production), promoting pro-inflammatory responses in vascular cells. Inhibition of S100-mediated RAGE and TLR4 activation may be a promising therapeutic approach for atherosclerosis, with S100A12 potentially serving as a biomarker for cardiovascular events.", "population_specificity": "Not specified (review of existing literature on vascular cells and atherosclerosis mechanisms).", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:38:30.394142+00:00"}
{"study_id": 101429, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to determine whether BMI, blood pressure, and cardiorespiratory fitness (CRF) are associated with subcutaneous AGEs formation in children.", "results_summary": "Children with higher physical fitness showed lower levels of AGEs, while BMI and blood pressure were not independently associated with AGEs. An increase in physical fitness was linked to a reduction in AGEs, independent of BMI and blood pressure.", "population_specificity": "1075 children aged 7.2 \u00b1 0.4 years", "effective_dosage": "Not available", "study_duration": "Not specified (cross-sectional study)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:38:30.395424+00:00"}
{"study_id": 101430, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": 50, "quality_score": 80, "study_goal": "The researchers aimed to compare the effects of protective ventilation versus conventional ventilation on pulmonary levels of biomarkers for inflammation and lung injury, including soluble Receptor for Advanced Glycation End-products (sRAGE), during one-lung ventilation in oesophagectomy patients.", "results_summary": "The study found no significant difference in changes in pulmonary levels of sRAGE and other biomarkers between protective and conventional ventilation strategies. Levels of sRAGE did not change significantly from start to end of ventilation in either group.", "population_specificity": "Twenty-nine patients scheduled for one-lung ventilation during oesophagectomy at a tertiary center for oesophageal diseases.", "effective_dosage": "Not applicable (ventilation parameters: low tidal volume of 6 ml/kg predicted body weight during two-lung ventilation and 3 ml/kg during one-lung ventilation vs. intermediate tidal volume of 10 ml/kg and 5 ml/kg, respectively).", "study_duration": "Intra-operative period (specific duration not mentioned).", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:38:33.094035+00:00"}
{"study_id": 101431, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to explore the role of extracellular HMGA1 and its interaction with RAGE in tumor migration, invasion, and metastasis in triple-negative breast cancer (TNBC).", "results_summary": "The study found that HMGA1 secretion and binding to RAGE mediates migration, invasion, and metastasis in TNBC cells and predicts metastasis onset. Targeting extracellular HMGA1 with monoclonal antibodies or combined therapies was proposed as a potential treatment strategy.", "population_specificity": "Triple-negative breast cancer (TNBC) cells and patients.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:38:33.732211+00:00"}
{"study_id": 101432, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the effects of resistant dextrin on cardiometabolic risk factors and oxidative stress, including advanced glycation end-products (AGEs), in women with type 2 diabetes mellitus.", "results_summary": "Resistant dextrin significantly reduced several AGEs (CML, pentosidine) and oxidative stress markers (MDA, 8-iso-PGF2\u03b1) while increasing sRAGE and total antioxidant capacity. No significant changes were observed in some other markers like pentosidine and antioxidant enzymes.", "population_specificity": "65 female subjects with type 2 diabetes mellitus.", "effective_dosage": "10 g/day of resistant dextrin.", "study_duration": "8 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:38:34.788866+00:00"}
{"study_id": 101433, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to compare the glycation potential of different glycating agents (glucose, fructose, ribose, methylglyoxal, and glyceraldehyde) on plasma, erythrocytes, platelets, and blood DNA to assess their effects on structural modifications and antioxidant indices.", "results_summary": "The study found that methylglyoxal and glyceraldehyde had the highest glycation potency, leading to significant increases in fructosamine and structural modification markers, along with depletion in antioxidant indices. These results suggest these agents cause more pronounced glycation-induced modifications in plasma and vascular cells compared to other glycating agents.", "population_specificity": "Plasma, erythrocytes, platelets, and blood DNA samples (in vitro study).", "effective_dosage": "Not specified (incubation with glycating agents for 24-48 hours).", "study_duration": "24-48 hours.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:38:35.847294+00:00"}
{"study_id": 101434, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to summarize the effects of type 1 and type 2 diabetes on bone tissue compositional and mechanical properties, particularly focusing on advanced glycation endproducts (AGEs).", "results_summary": "The study found that individuals with diabetes had increased bone mineralization and AGE concentrations, which correlated with altered mechanical properties\u2014higher stiffness and strength but reduced post-yield properties. Cortical resistance was lower in T2DM patients and worsened with poor glycemic control.", "population_specificity": "Individuals with type 1 and type 2 diabetes mellitus (T1DM, T2DM).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:38:36.604018+00:00"}
{"study_id": 101435, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to examine the potential link between added dietary sugars, including the generation of Advanced Glycation End Products (AGEs), and increased vulnerability to major depressive disorder.", "results_summary": "The study suggests that high-dose sugar intake, leading to AGEs, may contribute to depressive illness through mechanisms like systemic inflammation, oxidative stress, and disrupted neurobiological processes. The existing literature supports the hypothesized depressogenic impact of added sugars and AGEs.", "population_specificity": "General population, with a focus on those consuming contemporary Western diets high in added sugars.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:38:37.288388+00:00"}
{"study_id": 101436, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to review the biological and chemical pathways related to collagen crosslinking in diabetes mellitus (DM) and keratoconus (KC), focusing on the role of advanced glycation end products (AGEs).", "results_summary": "The study suggests that AGE-mediated crosslinking in DM may protect against KC development by increasing corneal rigidity, while riboflavin-mediated photoreactive crosslinking could stabilize KC progression by enhancing collagen fibril crosslinking.", "population_specificity": "General discussion of DM and KC patients, no specific population studied.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:38:37.872511+00:00"}
{"study_id": 101439, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": 40, "quality_score": 65, "study_goal": "The researchers aimed to summarize current knowledge on the pathogenic role of Advanced Glycation End Products (AGEs) in chronic noncommunicable diseases and evaluate intervention strategies.", "results_summary": "The study found that AGEs contribute to oxidative stress and inflammatory signaling pathways, correlating with chronic diseases, but clinical translation of anti-AGE strategies has been inconsistent. Future interventions require better-designed clinical trials and addressing lifestyle factors.", "population_specificity": "Not specified (general review of existing research)", "effective_dosage": "Not available", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:38:40.682784+00:00"}
{"study_id": 101437, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 80, "study_goal": "The researchers aimed to explore the role of food-derived advanced glycation end products (AGEs) in the progression of non-alcoholic fatty liver disease (NAFLD) to non-alcoholic steatohepatitis (NASH) and liver fibrosis, and to discuss potential dietary and therapeutic interventions targeting the AGE/RAGE pathway.", "results_summary": "The study found that both endogenous and food-derived AGEs activate the receptor for AGEs (RAGE), primarily on Kupffer cells and hepatic stellate cells, contributing to NAFLD progression to NASH and liver fibrosis. Dietary manipulation to reduce AGE content or therapies targeting the AGE/RAGE pathway may influence disease progression.", "population_specificity": "Adults with NAFLD, particularly those at risk of progression to NASH and liver fibrosis.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:38:40.737946+00:00"}
{"study_id": 101438, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 75, "study_goal": "The researchers aimed to assess associations between environmental and dietary factors (not specifically Advanced Glycation End Products) with allergic diseases in urban and rural South African children.", "results_summary": "The study found that exposure to farm animals and fermented milk products had protective effects against allergic outcomes, while factors like cesarean section, fast food consumption, and smoking were associated with increased allergy risks. Advanced Glycation End Products were not specifically addressed in the abstract.", "population_specificity": "Toddlers aged 12 to 36 months in urban and rural South Africa.", "effective_dosage": "Not mentioned", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:38:41.079817+00:00"}
{"study_id": 101440, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to evaluate skin autofluorescence (SAF) as a biomarker of advanced glycation end-products (AGEs) and its association with mortality and kidney disease progression.", "results_summary": "SAF was elevated in kidney disease patients, particularly those on dialysis, and higher SAF independently predicted increased mortality and kidney function decline. The discriminatory improvement over traditional risk factors was modest.", "population_specificity": "Adults and children with kidney disease, including dialysis patients, renal transplant recipients, and those with acute kidney injury.", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:38:42.114850+00:00"}
{"study_id": 101441, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to summarize the role of methylglyoxal (MGO) and MGO-derived advanced glycation end products (AGEs) in diabetes, vascular complications, and age-related diseases, and explore potential therapeutic strategies to mitigate MGO stress.", "results_summary": "The study found that MGO and MGO-derived AGEs contribute to diabetes, vascular complications, and other age-related diseases by affecting organ function and structure. It highlighted potential therapeutic strategies, including glyoxalase inducers and MGO scavengers, to target MGO burden.", "population_specificity": "Not specified (general discussion of disease mechanisms and potential interventions).", "effective_dosage": "Not specified.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:38:44.010998+00:00"}
{"study_id": 101443, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the potential of iron chelators (deferoxamine, deferasirox, deferiprone) as adjuvant drugs in managing obesity and its comorbidities, including their effects on advanced glycation end products.", "results_summary": "Iron chelators showed potential in controlling obesity-induced alterations in adipose tissue, liver, kidneys, and \u03b2-cells, with evidence of inhibiting advanced glycation end products. However, their systemic anti-inflammatory effects in human endotoxemia were not corroborated.", "population_specificity": "Obese patients and experimental obesity models (in vivo and in vitro).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:38:45.386233+00:00"}
{"study_id": 101442, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to explore the relationship between potential prognostic biomarkers, including extracellular newly identified receptor for advanced glycation end-products binding protein, and efficacy endpoints in Japanese patients with metastatic colorectal cancer treated with aflibercept plus FOLFIRI.", "results_summary": "Eight potential biomarkers, including extracellular newly identified receptor for advanced glycation end-products binding protein, correlated with overall survival in univariate analysis, but none correlated with progression-free survival or maximum tumor shrinkage. Pre-dose 3 biomarker levels did not correlate with any efficacy endpoints.", "population_specificity": "Japanese patients with metastatic colorectal cancer (n=62).", "effective_dosage": "Aflibercept (4 mg/kg) plus FOLFIRI every 2 weeks.", "study_duration": "Treatment administered every 2 weeks (specific total duration not stated).", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:38:46.540790+00:00"}
{"study_id": 101444, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the effects of photodynamic therapy (PDT) as an adjunct to full-mouth disinfection (FMD) on clinical periodontal parameters, serum HbA1c, and levels of advanced glycation end-products (AGEs) in gingival crevicular fluid (GCF) among patients with periodontitis and type 2 diabetes mellitus.", "results_summary": "Both groups showed significant reductions in clinical periodontal parameters and AGEs levels over time, with a minor, non-significant reduction in AGEs observed in the PDT group at 3 months. No significant difference in HbA1c levels was found between groups.", "population_specificity": "Thirty type 2 diabetes mellitus patients with mild to moderate periodontitis.", "effective_dosage": "Not specified", "study_duration": "6 months", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:38:46.547063+00:00"}
{"study_id": 101447, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to compare the behavior of advanced glycation end products (AGEs) and their soluble receptor (sRAGE) in patients with heart failure (HF) and acute coronary syndrome (ACS), and assess their prognostic value.", "results_summary": "Higher glycation parameters were observed in HF patients, with sRAGE forms directly related to glycation in HF but not ACS. esRAGE was an independent predictor of poor long-term prognosis in HF, but no AGE-RAGE variables predicted outcomes in ACS.", "population_specificity": "102 patients with ACS and 102 patients with chronic HF, matched by age and gender.", "effective_dosage": "Not specified", "study_duration": "5-year follow-up", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:38:49.323809+00:00"}
{"study_id": 101445, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to investigate the influence of glycation and advanced glycation end products (AGEs) on macrophage activity and cytokine expression to understand impaired wound healing in aging and diabetes.", "results_summary": "The study found that glycation increased pro-inflammatory cytokines (IL-1\u03b2, IL-8) and altered IL-10 and TNF-\u03b1 expression, leading to increased inflammation. Glycation also reduced macrophage phagocytic efficiency, impairing microbial and cellular debris clearance.", "population_specificity": "Macrophages in the context of diabetes and aging (not human subjects).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:38:50.046014+00:00"}
{"study_id": 101446, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to investigate the impact of ultra-protective ventilation settings on serum and pulmonary biotrauma markers, including soluble receptor for advanced glycation end-products (sRAGE), in severe acute respiratory distress syndrome patients on venovenous extracorporeal membrane oxygenation (ECMO).", "results_summary": "Ultra-protective ventilation settings post-ECMO initiation significantly reduced plasma sRAGE, interleukin-6, and monocyte chemotactic protein-1 levels, indicating reduced pulmonary biotrauma. The lowest bronchoalveolar lavage sRAGE levels were observed at minimal driving pressure, suggesting potential benefits of specific ventilation strategies.", "population_specificity": "Severe acute respiratory distress syndrome patients on venovenous ECMO.", "effective_dosage": "Not applicable (ventilation settings: bi-level positive airway pressure mode with varying high and low pressures).", "study_duration": "24 hours for initial intervention, followed by randomized experimental steps.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:38:50.604902+00:00"}
{"study_id": 101448, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to explore the pro- and anti-inflammatory activity of dietary components, including Advanced Glycation End Products (d-AGE), and their potential role in Alzheimer's disease prevention and treatment.", "results_summary": "The abstract suggests that dietary factors, including d-AGE, may modulate inflammation, which could influence Alzheimer's disease progression, but does not provide specific findings on d-AGE's effects.", "population_specificity": "Elderly population at risk for or with Alzheimer's disease (not explicitly stated but implied).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:38:51.753430+00:00"}
{"study_id": 101449, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the therapeutic properties of demethoxycurcumin (DMC) in noncancerous conditions, including its effects on advanced glycation end-products (AGEs) associated with diabetic nephropathy.", "results_summary": "DMC demonstrated beneficial pharmacological actions, including anti-inflammatory, neuroprotective, and antioxidative effects, and was found to ameliorate oxidative stress caused by AGEs in diabetic nephropathy. It also inhibited vascular smooth muscle cell migration and proliferation post-angioplasty.", "population_specificity": "Not specified (review of published literature).", "effective_dosage": "Not specified.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:38:51.907346+00:00"}
{"study_id": 101450, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to explore the role of Advanced Glycation End Products (AGEs) in the pathogenesis of microvascular and macrovascular complications in Type 1 Diabetes Mellitus (T1DM).", "results_summary": "The study highlights that AGEs, along with other factors like oxidative stress and sorbitol production, contribute to vascular damage in T1DM. It suggests that understanding these mechanisms could aid in early identification and treatment of diabetic complications, though further research is needed.", "population_specificity": "Children affected with Type 1 Diabetes Mellitus (T1DM).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:38:52.830319+00:00"}
{"study_id": 101451, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 60, "study_goal": "The researchers aimed to identify anti-glycation plants and their mechanisms to aid in finding natural remedies for diabetic complications.", "results_summary": "The review found that various plants inhibit glycation through multiple mechanisms, such as blocking Schiff base and Amadori product formation, preventing AGE aggregation, and exhibiting antioxidant activity to reduce AGE formation.", "population_specificity": "Not specified (review of existing studies)", "effective_dosage": "Not available", "study_duration": "Not applicable (review study)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:38:53.575714+00:00"}
{"study_id": 101452, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 75, "study_goal": "The researchers aimed to explore the potential connection between glycation and proteostasis imbalances in Huntington's disease (HD) and its possible contribution to disease progression.", "results_summary": "The abstract suggests that advanced glycation end products (AGEs) may accelerate protein aggregation and deposition in HD, potentially worsening disease progression, but the exact mechanisms remain unclear. Therapeutic interventions to mitigate glycation's negative impact in HD are also reviewed.", "population_specificity": "Huntington's disease (HD) patients and other CAG triplet repeat disorders.", "effective_dosage": "Not available", "study_duration": "Not available", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:38:54.257511+00:00"}
{"study_id": 101453, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to explore the neuroprotective role of fingolimod in Alzheimer's disease (AD) and its potential therapeutic effects, particularly its modulation of the receptor for advanced glycation end products (RAGE) signaling axis implicated in AD pathogenesis.", "results_summary": "The study found that fingolimod may suppress A\u03b2 secretion and deposition, inhibit apoptosis, enhance BDNF production, regulate neuroinflammation, protect against NMDA-excitotoxicity, and modulate RAGE signaling, suggesting potential benefits in AD progression.", "population_specificity": "The study discusses implications for Alzheimer's disease, but specific human or animal populations are not detailed in the abstract.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:38:57.479635+00:00"}
{"study_id": 101454, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 70, "study_goal": "The researchers aimed to identify the main fluorophores in skin and oral mucosa, including Advanced Glycation End Products, and explore their clinical applications.", "results_summary": "The study found that Advanced Glycation End Products are among the fluorophores in skin and oral mucosa, with potential clinical applications in glycemic control and skin aging markers. However, most studies had low levels of evidence, indicating a need for further research.", "population_specificity": "Not specified (general focus on skin and oral mucosa fluorophores)", "effective_dosage": "Not available", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:38:58.868624+00:00"}
{"study_id": 101455, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to investigate the clinical efficacy of recombinant human basic fibroblast growth factor combined with compound polymyxin B ointment and local insulin application on wound healing in diabetic patients with deep second-degree burns, focusing on AGEs and VEGF levels.", "results_summary": "The study found that the combined treatment significantly reduced AGEs levels, increased VEGF levels, and improved wound healing outcomes (shorter pain relief, scarring, and healing times) compared to the control group. It also lowered infection rates and complications.", "population_specificity": "80 diabetic patients with deep second-degree burns.", "effective_dosage": "Not specified.", "study_duration": "Follow-up at 3, 14, and 28 days post-treatment.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:38:58.884302+00:00"}
{"study_id": 101457, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 75, "study_goal": "The researchers aimed to review the role of HMGB1 in inflammatory diseases, particularly its interaction with receptors like RAGE (receptor for advanced glycation end products) and TLR-4.", "results_summary": "The abstract highlights HMGB1's involvement in inflammatory diseases through interactions with RAGE and TLR-4, but does not provide specific results on the effects of advanced glycation end products themselves.", "population_specificity": "Not specified (review article, not a clinical study).", "effective_dosage": "Not available.", "study_duration": "Not applicable (review article).", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:38:59.897285+00:00"}
{"study_id": 101456, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 75, "study_goal": "The researchers aimed to review current knowledge on the pathogenic role of Advanced Glycation End Products (AGEs) in metabolic, autoimmune, and neurological disorders and explore emerging therapeutic strategies.", "results_summary": "The abstract highlights that glycation is a contributing factor in various diseases, including diabetes, arthritis, lupus, and neurodegenerative conditions, and suggests it offers new drug targets and treatment insights. However, specific efficacy or safety outcomes are not detailed.", "population_specificity": "Not specified (general discussion of disease implications).", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:39:00.372600+00:00"}
{"study_id": 101459, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine the effect of resveratrol (RSV) on AGE-induced toxicity and its harmful consequences.", "results_summary": "Most studies showed RSV suppressed AGE production or RAGE activity, reducing oxidative stress, inflammation, immune reactions, insulin response issues, and atherosclerosis. RSV acted via RAGE, NF-\u03baB, PPAR\u03b3, and TGF-\u03b2 pathways.", "population_specificity": "Not specified (systematic review of 29 studies).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:39:00.666704+00:00"}
{"study_id": 101458, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to evaluate the relationship between serum levels of soluble Receptor for Advanced Glycation End-products (sRAGE) and mortality in frail and non-frail older adults.", "results_summary": "Higher sRAGE levels were significantly associated with increased mortality risk in frail individuals (HR = 2.72, P = 0.001), but no association was found in non-frail individuals. Survival analysis showed frail individuals in the top sRAGE quartile had significantly higher mortality rates.", "population_specificity": "691 older adults (141 frail, 550 non-frail) with a median age of 75 years from two population-based cohorts.", "effective_dosage": "Not specified", "study_duration": "6 years of follow-up", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:39:01.727865+00:00"}
{"study_id": 101460, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the effect of green tea extract on arterial stiffness parameters, lipids, body composition, and sRAGE levels in patients with Type 2 diabetes mellitus.", "results_summary": "The abstract does not provide specific results regarding the effects of green tea extract on the studied parameters.", "population_specificity": "Twenty normotensive patients with Type 2 diabetes mellitus, mean age 53.2 \u00b1 9.4 years, mean BMI 30.1 \u00b1 4.5 kg/m\u00b2, treated with standard therapy and statins.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:39:02.553640+00:00"}
{"study_id": 101464, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": null, "study_goal": "The researchers were examining the role of arterial stiffness in the pathophysiology of cardiorenal syndrome type 4, with a focus on pathogenic factors like uremic toxins.", "results_summary": "The abstract does not provide specific findings regarding Advanced Glycation End Products.", "population_specificity": "Patients with chronic kidney disease (CKD) leading to chronic cardiac dysfunction.", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:39:06.548302+00:00"}
{"study_id": 101463, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to explore the role of advanced glycation end-products (AGEs) in diabetic nephropathy (DN) pathogenesis and assess the potential of adiponectin and its receptor agonist AdipoRon in preventing glomerular hypertrophy.", "results_summary": "The study highlights that chronic hyperglycemia leads to AGE formation, glomerular hypertrophy, and podocyte instability, contributing to DN. Adiponectin and AdipoRon show therapeutic potential in preventing these structural changes, though efficacy remains uncertain.", "population_specificity": "Not specified (general focus on diabetic nephropathy).", "effective_dosage": "Not mentioned.", "study_duration": "Not mentioned.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:39:07.341649+00:00"}
{"study_id": 101461, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to investigate the role of Advanced Glycation End Products (AGEs) and their receptor RAGE in the pathogenesis of Alzheimer's disease (AD) and explore potential therapeutic interventions targeting AGE-RAGE stress.", "results_summary": "The study found that AGE-RAGE stress contributes to AD pathology by increasing reactive oxygen species (ROS), amyloid \u03b2 (A\u03b2) synthesis, and tau phosphorylation, leading to plaque formation and neurofibrillary tangles. Therapeutic strategies targeting AGE reduction, RAGE inhibition, and antioxidant use were suggested to mitigate AD progression.", "population_specificity": "Not specified (theoretical or general AD pathology focus)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:39:07.460590+00:00"}
{"study_id": 101462, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 50, "study_goal": "The researchers were attempting to determine the association between Type 2 diabetes mellitus and cognitive decline, including dementia subtypes like Alzheimer disease and vascular dementia, as well as a potential dementia subgroup linked to DM-related metabolic abnormalities.", "results_summary": "The study suggests that Type 2 diabetes mellitus increases the risk for cognitive decline and dementia, including Alzheimer disease and vascular dementia, and identifies a potential dementia subgroup associated with DM-related metabolic abnormalities rather than AD pathology or cerebrovascular diseases.", "population_specificity": "Individuals with Type 2 diabetes mellitus, particularly older adults with high hemoglobin A1c levels.", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:39:07.513559+00:00"}
{"study_id": 101466, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to explore the role of statins in improving diabetic complications linked to advanced glycation end products and reactive oxygen species.", "results_summary": "The abstract suggests that statins may help reverse diabetic complications through multiple pathways, including antioxidant, anti-inflammatory, and lipid-lowering effects, beyond glycemic control. However, specific outcomes related to advanced glycation end products are not detailed.", "population_specificity": "Patients with diabetes mellitus and associated complications.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:39:09.116328+00:00"}
{"study_id": 101465, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the relationship between serum pentosidine (an AGE) and arteriovenous fistula (AVF) morphology and function in hemodialysis patients.", "results_summary": "The study found that pentosidine correlated with various metabolic markers (e.g., cholesterol, triglycerides) and inversely with dialysis vintage, access vintage, and residual AVF diameter. Patients with higher pentosidine levels had higher cholesterol, triglycerides, and hypertension prevalence, suggesting a potential link between AGEs and AVF dysfunction.", "population_specificity": "88 hemodialysis patients with patent native AVF.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:39:10.122882+00:00"}
{"study_id": 103725, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 75, "study_goal": "The researchers explored the potential pathogenic role of \u03b2-methylamino-l-alanine (BMAA) in Parkinson's disease (PD), focusing on its interaction with metals and oxidative stress.", "results_summary": "The study suggests BMAA may contribute to PD by disrupting iron metabolism and increasing oxidative stress, but it does not provide direct experimental evidence of its effects. The abstract highlights potential therapeutic strategies like chelation therapy for PD.", "population_specificity": "Not specified (general discussion of PD mechanisms)", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:39:18.674605+00:00"}
{"study_id": 103721, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to evaluate the efficacy of TACE combined with HIFU in treating middle-advanced liver cancer, including its impact on liver function markers like alanine aminotransferase (ALT).", "results_summary": "The study found that TACE combined with HIFU significantly reduced ALT levels, improved liver function, enhanced immune response, and increased survival rates compared to TACE alone.", "population_specificity": "100 patients with middle-advanced liver cancer.", "effective_dosage": "Not specified", "study_duration": "Follow-up periods included 1-, 2-, 3-, and 5-year survival rates.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:39:18.737695+00:00"}
{"study_id": 103723, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to determine if HBsAg epitope profiles, including changes in alanine aminotransferase levels, could predict functional cure in chronic hepatitis B patients undergoing long-term nucleos(t)ide analogue therapy.", "results_summary": "The study found that HBsAg clearance profiles (CPs) correlated with functional cure outcomes, including alanine aminotransferase flares and anti-HBs complexed with HBsAg, suggesting a predictive biomarker role.", "population_specificity": "25 genotype A chronic hepatitis B patients (HBeAg-positive) treated with tenofovir or adefovir.", "effective_dosage": "Not specified", "study_duration": "4 years", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:39:19.188241+00:00"}
{"study_id": 103724, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 75, "study_goal": "The study aimed to evaluate the toxicity rates and efficacy of postoperative radiation therapy (RT) for cholangiocarcinoma patients, including monitoring alanine transaminase levels as part of radiation-induced hepatic toxicity (RIHT) assessment.", "results_summary": "The study found significant associations between radiation dose parameters (V30, V40) and \u2265grade 2 RIHT, which included alanine transaminase levels. Grade \u22652 RIHT rates also differed significantly by sex.", "population_specificity": "Postoperative cholangiocarcinoma patients who underwent partial liver resection and RT (n=32).", "effective_dosage": "Median prescribed total dose was 50\u200aGy (radiation therapy, not alanine supplementation).", "study_duration": "Median follow-up time was 27 months.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:39:20.185246+00:00"}
{"study_id": 103727, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to determine whether patients with negative HBV DNA and RNA test results (double negative) at the end of treatment maintained a long-term response after discontinuation of nucleos(t)ide analogue therapy for chronic HBV infection.", "results_summary": "The study found that double-negative patients had significantly lower clinical relapse rates (8.0% vs. 31.4%) after 4 years off treatment compared to those positive for either HBV DNA or RNA. These findings were validated in a second cohort, though the difference was not statistically significant (15.4% vs. 33.3%).", "population_specificity": "HBeAg-positive patients with chronic HBV infection (mean age ~30-36 years, ~72% male).", "effective_dosage": "Not specified", "study_duration": "Treatment duration varied; follow-up lasted up to 5.5 years after discontinuation.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:39:20.321487+00:00"}
{"study_id": 103722, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 88, "study_goal": "The researchers aimed to assess the safety and efficacy of magnesium isoglycyrrhizinate (MgIG) compared to tiopronin for treating drug-induced liver injury (DILI), focusing on alanine aminotransferase (ALT) normalization.", "results_summary": "The study found that both low and high doses of MgIG significantly increased ALT normalization rates at week 4 compared to the active control (tiopronin), with odds ratios of 3.55 and 3.83, respectively. The results suggest MgIG is effective for acute DILI treatment.", "population_specificity": "174 subjects with drug-induced liver injury (DILI) in China.", "effective_dosage": "Not specified (low and high doses of MgIG compared to tiopronin).", "study_duration": "4 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:39:20.736103+00:00"}
{"study_id": 103726, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 75, "study_goal": "The researchers were evaluating the adverse events associated with the use of zidovudine (ZDV)/lamivudine (3TC)/nevirapine (NVP) for neonatal postexposure prophylaxis (PEP) in HIV-exposed infants, not specifically studying Alanine.", "results_summary": "The study found that triple antiretroviral neonatal PEP with ZDV/3TC/NVP for 6 weeks in high-risk HIV-exposed infants did not significantly increase the risk of short-term toxicity compared with ZDV-monotherapy prophylaxis, but did observe higher rates of grade 2 anemia in the triple regimen group at 1 month. No differences in neutropenia or hepatotoxicity were noted between regimens.", "population_specificity": "High-risk and low-risk HIV-exposed infants in Thailand.", "effective_dosage": "Not specified for Alanine.", "study_duration": "6 weeks for high-risk infants, 4 weeks for low-risk infants.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:39:21.071516+00:00"}
{"study_id": 103720, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 75, "study_goal": "The researchers aimed to compare the long-term efficacy and safety of islet transplantation (ITx) versus multiple daily injections (MDI) or continuous subcutaneous insulin infusion (CSII) in patients with type 1 diabetes, with a focus on glycemic control and clinical events.", "results_summary": "The study found that ITx significantly improved hemoglobin A1c levels at 1 year compared to MDI/CSII, with maintained benefits at 2 years. ITx also reduced severe hypoglycemia but was associated with higher rates of infectious diseases and digestive symptoms.", "population_specificity": "Patients with insulin-dependent diabetes mellitus or type 1 diabetes, specifically seven in the ITx group and 26 in the MDI/CSII group, all with no endogenous insulin secretion.", "effective_dosage": "Not mentioned", "study_duration": "Follow-up assessments at 1, 2, 5, and 10 years.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:39:21.303792+00:00"}
{"study_id": 103729, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 75, "study_goal": "The researchers aimed to review the role of CD26 (DPP-4) in autoimmune diseases, including its interaction with peptides containing alanine.", "results_summary": "The abstract highlights that DPP-4, which cleaves peptides with alanine in the second position, plays a key role in T cell immunity and may be a potential target for autoimmune diseases. However, no direct effects of alanine itself are discussed.", "population_specificity": "Not specified (review paper, not a clinical study)", "effective_dosage": "Not available", "study_duration": "Not applicable", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:39:26.490355+00:00"}
{"study_id": 103730, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 85, "study_goal": "The researchers aimed to assess the effects of remote ischemic preconditioning (RIPC) on liver function in donors and recipients after living donor liver transplantation, focusing on markers like alanine aminotransferase levels.", "results_summary": "RIPC did not improve liver function in donors but was associated with significantly lower AST levels in recipients, though it did not reduce early allograft dysfunction or graft failure rates.", "population_specificity": "Living liver donors and recipients undergoing liver transplantation.", "effective_dosage": "3 cycles of 5-minute inflation of a blood pressure cuff to 200 mm Hg, followed by 5-minute reperfusion.", "study_duration": "Single session (intervention duration not explicitly stated beyond the cycles).", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:39:27.399004+00:00"}
{"study_id": 103731, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": 50, "quality_score": 75, "study_goal": "The researchers aimed to compare the efficacy and safety of S-1 and capecitabine in patients with metastatic colorectal carcinoma (mCRC), including the effects on alanine transaminase levels.", "results_summary": "The study found no statistical difference in efficacy (ORR, DCR, PFS, OS) between S-1 and capecitabine. Elevated alanine transaminase showed no significant difference between the groups, but diarrhea was more prevalent with S-1, while hand-foot syndrome was more frequent with capecitabine.", "population_specificity": "Patients with metastatic colorectal carcinoma (mCRC)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:39:27.416940+00:00"}
{"study_id": 103734, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 80, "study_goal": "The researchers aimed to assess the risk of hepatocellular carcinoma (HCC) in patients with chronic hepatitis B who were outside current treatment recommendations, focusing on factors like alanine aminotransferase levels.", "results_summary": "The study found that elevated alanine aminotransferase levels, along with other factors, were independently associated with HCC development in untreated patients. Patients outside treatment criteria still had significant HCC risk, particularly those with specific risk factors.", "population_specificity": "Patients with chronic hepatitis B who were monitored without antiviral treatment (n=3624).", "effective_dosage": "Not specified", "study_duration": "Median follow-up of 4.6 years", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:39:29.002555+00:00"}
{"study_id": 103733, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to compare the diagnostic performance of MRE and 2D-SWE with serum-based indices (FIB-4 and APRI) for identifying significant fibrosis and cirrhosis in CHB patients with normal or mildly elevated ALT levels.", "results_summary": "MRE demonstrated superior diagnostic accuracy for detecting significant fibrosis (\u2265 F2) compared to 2D-SWE and serum-based indices, suggesting it may be a more precise non-invasive tool for deciding antiviral therapy initiation in CHB patients.", "population_specificity": "Treatment-na\u00efve chronic hepatitis B (CHB) patients with high viral loads and normal or mildly elevated ALT levels (n=63).", "effective_dosage": "Not available", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:39:29.147994+00:00"}
{"study_id": 103736, "supplement_id": 863, "safety_score": "90", "efficacy_score": 50, "quality_score": 85, "study_goal": "The researchers aimed to determine whether 16 weeks of methylsulfonylmethane (MSM) supplementation caused adverse effects on metabolic and physiologic parameters in patients with musculoskeletal disorders.", "results_summary": "The study found no significant differences in hematologic, liver, kidney function, or physiologic parameters between MSM and placebo groups, indicating MSM had no adverse effects. However, efficacy in treating musculoskeletal disorders was not assessed.", "population_specificity": "Patients with osteoarthritis and back pain at a military medical center.", "effective_dosage": "6 g daily of MSM (OptiMSM\u00ae)", "study_duration": "16 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:39:29.267808+00:00"}
{"study_id": 103732, "supplement_id": 863, "safety_score": "80", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to assess the efficacy and safety of two doses of norursodeoxycholic acid (a homologue of ursodeoxycholic acid) compared to placebo in treating non-alcoholic fatty liver disease, with a focus on changes in serum alanine aminotransferase (ALT) concentrations.", "results_summary": "The study found a dose-dependent reduction in serum ALT levels, with the 1500 mg dose showing a significant mean reduction of -27.8% compared to placebo. Norursodeoxycholic acid was well-tolerated, with adverse events distributed similarly across treatment and placebo groups.", "population_specificity": "Patients with non-alcoholic fatty liver disease, with or without diabetes, and elevated serum ALT levels.", "effective_dosage": "500 mg/day and 1500 mg/day of norursodeoxycholic acid.", "study_duration": "12 weeks of treatment followed by a 4-week follow-up.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:39:30.367538+00:00"}
{"study_id": 103735, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 75, "study_goal": "The researchers aimed to investigate the activity of pazopanib, an antiangiogenic drug, in patients with advanced extraskeletal myxoid chondrosarcoma, not specifically Alanine.", "results_summary": "The study found that pazopanib had clinically meaningful antitumour activity in patients with progressive and advanced extraskeletal myxoid chondrosarcoma, with 18% achieving an objective response. Increased concentration of alanine aminotransferase was noted as a frequent grade 3 adverse event.", "population_specificity": "Adult patients (aged \u226518 years) with NR4A3-translocated, metastatic, or unresectable extraskeletal myxoid chondrosarcoma.", "effective_dosage": "Not applicable (study focused on pazopanib, not Alanine).", "study_duration": "Until disease progression, unacceptable toxicity, death, non-compliance, patient refusal, or investigator's decision.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:39:31.331507+00:00"}
{"study_id": 103739, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the effect of cornelian cherry extract supplementation on liver function markers, including Alanine aminotransferase (ALT), in patients with NAFLD.", "results_summary": "The abstract does not provide specific results regarding Alanine's effects, as the study appears to be in the planning or early stages (trial registration mentioned).", "population_specificity": "80 patients with nonalcoholic fatty liver disease (NAFLD).", "effective_dosage": "320 mg/day of cornelian cherry extract (exact frequency not specified).", "study_duration": "Not specified in the abstract.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:39:35.030152+00:00"}
{"study_id": 103740, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": 77, "quality_score": 75, "study_goal": "The researchers aimed to determine if short-term changes in serum alanine aminotransferase (ALT) levels after corticosteroid treatment could help differentiate between drug-induced liver injury (DILI) and autoimmune hepatitis (AIH).", "results_summary": "The study found that a significant decrease in ALT levels one week after starting corticosteroid therapy was more pronounced in DILI patients compared to AIH patients, with an accuracy of 77%. This difference was also observed in initially misclassified or inconclusive cases (accuracy 83%).", "population_specificity": "44 patients with acute liver injury (ALI) who took at least one drug and received corticosteroids (22 DILI and 22 AIH cases).", "effective_dosage": "Not specified", "study_duration": "1 week", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:39:37.403736+00:00"}
{"study_id": 103737, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 70, "study_goal": "The researchers aimed to identify patient- and treatment-related variables predictive for radioembolization outcome in patients with intra-hepatic cholangiocarcinoma (IH-CCA), including the role of alanine aminotransferase (ALT) levels.", "results_summary": "Elevated alanine aminotransferase (ALT) levels were associated with worse overall survival (HR = 2.02, 95%CI:1.05-3.90, p = 0.01), indicating a potential prognostic role in IH-CCA patients undergoing radioembolization.", "population_specificity": "Patients with unresectable and chemorefractory intra-hepatic cholangiocarcinoma (IH-CCA).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:39:38.132667+00:00"}
{"study_id": 103738, "supplement_id": 863, "safety_score": "90", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the effectiveness and safety of HuoXueHuaYu (HXHY) therapy in treating nonalcoholic fatty liver disease (NAFLD), including its impact on alanine transaminase (ALT) levels.", "results_summary": "HXHY significantly improved liver function by reducing ALT and AST levels, lowered total cholesterol and triglycerides, and enhanced B ultrasonic level and effective rate compared to conventional treatment, with no serious adverse reactions reported.", "population_specificity": "1429 patients with NAFLD (775 in HXHY group, 654 in conventional treatment group).", "effective_dosage": "Not specified in the abstract.", "study_duration": "Not specified in the abstract.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:39:38.704603+00:00"}
{"study_id": 103745, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to determine the factors associated with fatty liver remission in patients with type 2 diabetes treated with ipragliflozin, focusing on changes in alanine aminotransferase (ALT) levels as part of the fatty liver index (FLI).", "results_summary": "The study found that ipragliflozin significantly improved FLI, including reductions in ALT levels, with baseline FLI being an independent predictor of remission. Patients with lower baseline FLI were more likely to achieve remission.", "population_specificity": "200 Japanese patients with type 2 diabetes and fatty liver.", "effective_dosage": "50 mg/day of ipragliflozin.", "study_duration": "24 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:39:38.881921+00:00"}
{"study_id": 103742, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to investigate the long-term effects of SGLT-2 inhibitors on liver function and body weight in patients with NAFLD and type 2 diabetes.", "results_summary": "SGLT-2i treatment significantly reduced body weight, AST, and ALT levels over 12-24 months, with greater improvements in patients with higher baseline ALT levels. It also reduced CAP and Vs values, indicating improved liver health.", "population_specificity": "22 diabetic patients with NAFLD (15 followed up to 24 months).", "effective_dosage": "Not specified", "study_duration": "12-24 months", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:39:40.142456+00:00"}
{"study_id": 103743, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": null, "study_goal": "The study does not address Alanine; it evaluates the safety and efficacy of nivolumab with or without GS-4774 in virally suppressed HBeAg-negative chronic HBV patients.", "results_summary": "The study found that nivolumab was well-tolerated and led to HBsAg decline in most patients, with sustained HBsAg loss in one patient. No grade 3 or 4 adverse events were reported.", "population_specificity": "Virally suppressed HBeAg-negative chronic HBV patients", "effective_dosage": "Nivolumab at 0.1 mg/kg (n=2) or 0.3 mg/kg (n=12), or GS-4774 at 40 yeast units at baseline and week 4 plus nivolumab 0.3 mg/kg at week 4 (n=10)", "study_duration": "Follow-up through week 24", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:39:41.991540+00:00"}
{"study_id": 103746, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": 30, "quality_score": 65, "study_goal": "The researchers were evaluating the antitumor activity and safety of nivolumab in patients with metastatic adrenocortical carcinoma (ACC), not specifically studying Alanine.", "results_summary": "The study found modest antitumor activity with nivolumab, with two patients achieving stable disease and one unconfirmed partial response. Most adverse events were grade 1/2, with some grade 3/4 events including alanine aminotransferase elevations.", "population_specificity": "Adult patients with metastatic ACC previously treated with platinum-based chemotherapy and/or mitotane, or those who declined front-line chemotherapy.", "effective_dosage": "Nivolumab (240 mg) IV every 2 weeks.", "study_duration": "Median follow-up was 4.5 months (range, 0.1 to 25.6 months).", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:39:42.050827+00:00"}
{"study_id": 103747, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the effects of hesperidin supplementation on nonalcoholic fatty liver disease (NAFLD) characteristics, including alanine aminotransferase levels.", "results_summary": "Hesperidin supplementation significantly reduced alanine aminotransferase, \u03b3-glutamyltransferase, total cholesterol, triglyceride, hepatic steatosis, and inflammatory markers compared to placebo, suggesting benefits for NAFLD management.", "population_specificity": "50 NAFLD patients", "effective_dosage": "1-g hesperidin capsule daily", "study_duration": "12 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:39:42.828089+00:00"}
{"study_id": 103748, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": 45, "quality_score": 75, "study_goal": "The researchers aimed to clarify the effect of vitamin D supplementation on liver enzyme levels, specifically alanine aminotransferase, in patients with NAFLD.", "results_summary": "The pooled analysis did not reveal a significant effect of vitamin D intake on alanine aminotransferase levels (-2.88 U/L; 95% CI, -6.03 to 0.27). The study found no strong evidence supporting the efficacy of vitamin D supplementation for improving liver enzymes in NAFLD patients.", "population_specificity": "Patients with nonalcoholic fatty liver disease (NAFLD).", "effective_dosage": "Not specified in the abstract.", "study_duration": "Not specified in the abstract.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:39:45.452202+00:00"}
{"study_id": 103750, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 75, "study_goal": "The researchers were investigating the efficacy and safety of pembrolizumab in patients with advanced hepatocellular carcinoma (HCC), not specifically studying alanine.", "results_summary": "The study reported that pembrolizumab showed activity in advanced HCC, with some patients achieving complete or partial responses, but did not focus on alanine's effects.", "population_specificity": "Patients with advanced hepatocellular carcinoma (HCC) who had disease progression, intolerance, or refusal of sorafenib.", "effective_dosage": "Not applicable (study did not focus on alanine).", "study_duration": "Not applicable (study did not focus on alanine).", "interactions": "None mentioned (study did not focus on alanine).", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:39:46.686893+00:00"}
{"study_id": 103749, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 85, "study_goal": "The study aimed to evaluate the safety and efficacy of pyronaridine-artesunate for treating Plasmodium falciparum malaria, with incidental observations on transient increases in alanine transaminase levels.", "results_summary": "The study noted asymptomatic transient increases in alanine transaminase and aspartate transaminase at Day 7, which resolved by Day 28, but did not focus on alanine's effects.", "population_specificity": "Adults and children with microscopically confirmed P. falciparum malaria in five Vietnamese provinces.", "effective_dosage": "Not specified for alanine (study focused on pyronaridine-artesunate).", "study_duration": "3 consecutive days of treatment, with follow-up until Day 42.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:39:47.912621+00:00"}
{"study_id": 103751, "supplement_id": 863, "safety_score": "75", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to evaluate the safety and efficacy of evinacumab, an ANGPTL3 inhibitor, in reducing triglycerides and other lipids in hypertriglyceridemic subjects.", "results_summary": "Evinacumab was well-tolerated with no serious adverse events, and it significantly reduced triglycerides (up to 83.1%) and other lipids in hypertriglyceridemic subjects.", "population_specificity": "Subjects with triglycerides >150 but \u2264450 mg/dL and low-density lipoprotein cholesterol \u2265100 mg/dL.", "effective_dosage": "Subcutaneous doses of 75/150/250 mg (single dose) or 150/300/450 mg weekly/300/450 mg biweekly; intravenous doses of 5/10/20 mg/kg (single dose) or 20 mg/kg every 4 weeks.", "study_duration": "Up to 126 days for single-dose study and up to 56 days with 6 months follow-up for multiple-dose study.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:39:48.799750+00:00"}
{"study_id": 103752, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to analyze factors determining the biochemical response (normalized ALT/GGT) of DAA therapy in patients with hepatitis C virus (HCV) and assess the association of persistently elevated liver function tests with clinical outcomes.", "results_summary": "The study found that persistently elevated ALT and GGT after DAA therapy were associated with factors like high BMI, liver cirrhosis, diabetes, and alcohol consumption, and were linked to hepatic decompensation and mortality during follow-up. Most patients achieved SVR12, but elevated liver tests post-treatment indicated the need for further hepatological follow-up in high-risk patients.", "population_specificity": "Patients with hepatitis C virus (HCV) from a large real-world cohort in the German Hepatitis C-Registry.", "effective_dosage": "Not specified", "study_duration": "Follow-up at week 12 after end of therapy and over 4 years.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:39:49.689376+00:00"}
{"study_id": 103755, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 85, "study_goal": "The researchers aimed to evaluate the utility of noninvasive biomarkers, including alanine aminotransferase (ALT), for assessing advanced fibrosis in HBV/HIV co-infected adults on combined antiretroviral therapy.", "results_summary": "The study found that 54% of participants had normal ALT levels, but ALT itself was not directly evaluated as a biomarker for fibrosis. VCTE was identified as a superior biomarker compared to APRI or FIB-4 for detecting advanced fibrosis.", "population_specificity": "HBV/HIV co-infected adults receiving combined antiretroviral therapy from eight clinical sites in the United States and Canada.", "effective_dosage": "Not available", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:39:51.029720+00:00"}
{"study_id": 103753, "supplement_id": 863, "safety_score": "28", "efficacy_score": 82, "quality_score": 88, "study_goal": "The researchers aimed to evaluate the safety and efficacy of pexidartinib, a CSF1 receptor inhibitor, in treating symptomatic, advanced TGCT not amenable to surgery.", "results_summary": "Pexidartinib showed a robust tumor response (39% overall response rate) compared to placebo, but was associated with significant adverse events, including hepatotoxicity, hair color changes, and fatigue.", "population_specificity": "Patients with symptomatic, advanced tenosynovial giant cell tumor (TGCT) for whom surgery was not recommended.", "effective_dosage": "Loading dose of 1000 mg/day (400 mg morning, 600 mg evening) for 2 weeks, followed by 800 mg/day (400 mg twice daily) for 22 weeks.", "study_duration": "24 weeks (2 weeks loading dose + 22 weeks maintenance).", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:39:52.155179+00:00"}
{"study_id": 103754, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": null, "study_goal": "The researchers aimed to assess the risk of HBV reactivation in psoriasis patients undergoing various immunosuppressive therapies, including monitoring alanine aminotransferase levels.", "results_summary": "The study found that alanine aminotransferase monitoring is recommended every 3 months for HBV surface antigen-positive patients on certain therapies (e.g., methotrexate, acitretin, apremilast) due to low but present reactivation risk. No conclusive data were available for interleukin-17/23 inhibitors.", "population_specificity": "Psoriasis patients with chronic HBV or HCV infections.", "effective_dosage": "Not specified", "study_duration": "Monitoring every 3 months during therapy and 6-12 months post-therapy for high/moderate-risk treatments.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:39:52.180098+00:00"}
{"study_id": 103756, "supplement_id": 863, "safety_score": "90", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to summarize the effects of Saroglitazar, including its impact on alanine aminotransferase levels, in patients with diabetic dyslipidemia in real-world clinical studies.", "results_summary": "Saroglitazar improved alanine aminotransferase levels and fatty liver in non-alcoholic fatty liver disease patients with diabetic dyslipidemia, alongside consistent improvements in lipid and glycemic parameters without significant adverse events.", "population_specificity": "Patients with diabetic dyslipidemia, mean age 49.6 to 59.1 years, 22% to 42% female.", "effective_dosage": "4 mg once daily", "study_duration": "12 to 58 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:39:53.770237+00:00"}
{"study_id": 103757, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to investigate the efficacy and safety of autologous stem cell transplantation for treating viral hepatitis-induced liver cirrhosis, including its effects on alanine aminotransferase levels.", "results_summary": "The study found that autologous stem cell transplantation significantly decreased alanine aminotransferase levels (WMD: -9.16, 95% CI: -16.47 to -1.85, P = 0.01) and improved liver function markers, with no procedure-related complications reported.", "population_specificity": "Patients with viral hepatitis-induced liver cirrhosis (467 participants across eight trials).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:39:55.036445+00:00"}
{"study_id": 103758, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 60, "study_goal": "The researchers aimed to describe the potential benefits and practical use of alanine and other amino acids in cosmeceuticals, focusing on their role as natural moisturizing factors and skin-conditioning agents.", "results_summary": "The study found that alanine, as a monomeric amino acid, functions as a natural moisturizing factor in skin care, improving hydration and skin barrier function. It also highlighted the broader use of amino acids and peptides in cosmetics for anti-aging and skin repair benefits.", "population_specificity": "Not specified (general cosmetic and therapeutic applications)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:39:56.189877+00:00"}
{"study_id": 103759, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to evaluate the effect of phytosomal curcumin on serum adiponectin and leptin levels in patients with NAFLD, indirectly assessing markers like alanine aminotransferase (ALT).", "results_summary": "The study found that phytosomal curcumin significantly increased HDL-C and adiponectin levels while decreasing leptin levels and the leptin:adiponectin ratio in NAFLD patients. ALT levels were measured but specific effects on alanine metabolism were not highlighted.", "population_specificity": "65 patients with non-alcoholic fatty liver disease (NAFLD).", "effective_dosage": "Not specified for alanine; curcumin dosage not detailed in abstract.", "study_duration": "8 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:39:58.210169+00:00"}
{"study_id": 103760, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 75, "study_goal": "The researchers aimed to investigate the clinical characteristics and risk factors for death in allopurinol-induced severe cutaneous adverse reactions (SCARs) in Korea, including the role of alanine aminotransferase levels as a predictive factor.", "results_summary": "The study found that elevated baseline and peak alanine aminotransferase levels were significant risk factors for death in allopurinol-induced Stevens-Johnson syndrome/toxic epidermal necrolysis (SJS/TEN). No significant differences in mortality were observed in drug reaction with eosinophilia and systemic symptoms (DRESS) related to alanine aminotransferase levels.", "population_specificity": "106 subjects with allopurinol-induced SCARs and 639 subjects with other drug-induced SCARs from the Korean SCARs Registry (2010-2015).", "effective_dosage": "Not available", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:39:59.535190+00:00"}
{"study_id": 103762, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to determine whether probiotic supplementation in low birth weight infants affects gut microbiota composition and function, including pathways involving alanine metabolism.", "results_summary": "The study found that probiotic supplementation enhanced alanine metabolic pathways in the gut microbiota of low birth weight infants, alongside other beneficial metabolic effects.", "population_specificity": "Low birth weight infants (41 in the non-probiotic group, 56 in the probiotic group).", "effective_dosage": "Not specified (probiotic Bifidobacterium lactis was included in the formula).", "study_duration": "Fecal samples were collected at 14 days after birth.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:40:00.411960+00:00"}
{"study_id": 103761, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 75, "study_goal": "The researchers aimed to examine associations between high-intensity binge drinking (HIBD) and lipid/liver function enzyme (LFT) levels, including alanine aminotransferase (ALT), in a cross-sectional sample.", "results_summary": "The study found that HIBD was associated with significantly increased odds of clinically high levels of ALT and other LFTs, with higher binge levels correlating with greater odds.", "population_specificity": "Adults recruited from NIAAA screening protocols or inpatient alcohol treatment programs (mean age 39.7 years, 64.4% male, 47.3% white).", "effective_dosage": "Not specified (self-reported alcohol consumption stratified by binge levels).", "study_duration": "Cross-sectional data collected from 2005 to 2017.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:40:00.829528+00:00"}
{"study_id": 103764, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": 50, "quality_score": 85, "study_goal": "The researchers aimed to compare the efficacy and safety of S-1-based regimens versus intravenous fluorouracil-based regimens in Asian patients with metastatic colorectal carcinoma (mCRC), including the impact on alanine aminotransferase concentration.", "results_summary": "The study found no significant differences in alanine aminotransferase concentration between S-1-based and fluorouracil-based regimens, indicating no adverse effects specific to alanine. Other adverse events like leucopenia, neutropenia, and vomiting were lower in the S-1 group.", "population_specificity": "Asian patients with metastatic colorectal carcinoma (mCRC)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:40:00.935070+00:00"}
{"study_id": 103765, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 85, "study_goal": "The researchers aimed to compare the benefits and drawbacks of laparoscopic left hemihepatectomy (LLH) versus open left hemihepatectomy (OLH), including postoperative outcomes such as alanine transferase levels.", "results_summary": "The study found no significant differences in postoperative alanine transferase levels between LLH and OLH groups. LLH showed advantages in reduced blood loss, transfusion requirements, and hospital stay but had higher bile leakage rates and costs.", "population_specificity": "Patients undergoing left hemihepatectomy (1163 patients across 13 trials).", "effective_dosage": "Not applicable", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:40:02.310857+00:00"}
{"study_id": 103767, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 75, "study_goal": "The study aimed to analyze the epidemiological and clinical characteristics of chronic hepatitis C patients in South Korea, including treatment patterns before and after the approval of direct-acting antivirals, but did not specifically focus on Alanine.", "results_summary": "The study reported the mean alanine aminotransaminase level was within the upper normal limit at 49.9%, but did not evaluate Alanine's effects or safety.", "population_specificity": "2,758 patients with hepatitis C virus viremia in South Korea.", "effective_dosage": "Not available", "study_duration": "Not applicable", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:40:04.147593+00:00"}
{"study_id": 103766, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to investigate the effects of bioavailability-enhanced curcumin (combined with piperine) on serum hepatic enzymes, lipid profile, and glycemic indices in patients with NAFLD, including its impact on alanine aminotransferase (ALT) levels.", "results_summary": "Supplementation with curcuminoids plus piperine significantly reduced serum alanine aminotransferase (ALT) levels (P = 0.035) and improved NAFLD severity (P < 0.001), though changes in other parameters were not statistically different between groups except for albumin.", "population_specificity": "70 subjects with ultrasound-determined nonalcoholic fatty liver disease (NAFLD).", "effective_dosage": "500 mg curcuminoids coadministered with 5 mg piperine daily.", "study_duration": "12 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:40:04.555975+00:00"}
{"study_id": 103768, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 65, "study_goal": "The researchers aimed to compare the safety and efficacy of various lipid emulsions (LE), including fish oil-containing LE, for parenteral nutrition in term and late preterm infants, particularly focusing on outcomes like PNALD/cholestasis.", "results_summary": "The study found insufficient evidence to determine the benefit of any specific LE, including fish oil-containing LE, over others for preventing or resolving PNALD/cholestasis. Some evidence suggested fish oil-containing LE might reduce cholestasis in infants with PNALD, but the quality of evidence was very low.", "population_specificity": "Term and late preterm infants (34 weeks' gestation to 36 weeks and 6 days), with or without surgical conditions or PNALD.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:40:07.352735+00:00"}
{"study_id": 103769, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": 50, "quality_score": 85, "study_goal": "The researchers aimed to determine whether leucine supplementation (compared to alanine placebo) combined with resistance training improves insulin sensitivity in prefrail and frail older women.", "results_summary": "The study found no significant effects of leucine supplementation (vs. alanine) on insulin sensitivity or postprandial glucose/insulin responses. Both groups showed increased lean body mass and reduced body fat, likely due to resistance training.", "population_specificity": "Nondiabetic prefrail and frail older women (mean age 77.5 years, BMI 25.1).", "effective_dosage": "7.5 g/day of L-alanine (placebo).", "study_duration": "3 months.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:40:07.644943+00:00"}
{"study_id": 103770, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to investigate the metabolic benefits of saxagliptin and its effects on serum bile acids in normal weight and overweight/obese drug-na\u00efve type 2 diabetes patients.", "results_summary": "The study found that saxagliptin significantly improved glycemic control and metabolic parameters, particularly in overweight/obese patients, and increased bile acid concentrations, which were associated with metabolic improvements.", "population_specificity": "282 drug-na\u00efve type 2 diabetes patients (123 normal weight, 159 overweight/obese).", "effective_dosage": "Not specified", "study_duration": "24 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:40:07.957088+00:00"}
{"study_id": 103772, "supplement_id": 863, "safety_score": "85", "efficacy_score": 90, "quality_score": 95, "study_goal": "The researchers aimed to evaluate the long-term efficacy and safety of tenofovir disoproxil fumarate (TDF) in chronic hepatitis B (CHB) patients, including its impact on alanine aminotransferase (ALT) normalization.", "results_summary": "At Year 10, 100% of HBeAg-negative and 98% of HBeAg-positive patients achieved virological suppression, while 83% and 78% achieved ALT normalization, respectively. TDF demonstrated a favorable safety profile with no resistance documented and minimal renal or bone-related adverse events.", "population_specificity": "Chronic hepatitis B patients (HBeAg-negative and HBeAg-positive).", "effective_dosage": "Not specified in the abstract.", "study_duration": "Up to 10 years.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:40:10.406848+00:00"}
{"study_id": 103771, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to investigate whether yogurt (containing alanine) could improve insulin resistance, liver fat, gut microbiota, and biomarkers of inflammation and oxidative stress in obese women with NAFLD and metabolic syndrome.", "results_summary": "Yogurt significantly reduced insulin resistance, liver fat, serum lipids, inflammation, oxidative stress, and LPS levels compared to milk, while also altering gut microbiota composition. Mediation analysis suggested yogurt's benefits on insulin resistance were linked to improvements in lipid metabolism, inflammation, and gut microbiota.", "population_specificity": "Obese Chinese women aged 36-66 years with both NAFLD and metabolic syndrome.", "effective_dosage": "220 g/day of conventional yogurt", "study_duration": "24 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:40:11.043004+00:00"}
{"study_id": 103774, "supplement_id": 863, "safety_score": "90", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the antihypertensive efficacy and safety of a standardized Vaccinium arctostaphylos berry extract, including its impact on alanine aminotransferase (ALT) levels, in overweight/obese hypertensive patients.", "results_summary": "The study found that the extract significantly reduced systolic and diastolic blood pressure without affecting ALT levels or other measured parameters. No adverse effects or drug interactions were observed.", "population_specificity": "Overweight/obese hypertensive patients", "effective_dosage": "400 mg capsule three times daily", "study_duration": "3 months", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:40:11.421946+00:00"}
{"study_id": 103775, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": 20, "quality_score": 75, "study_goal": "The researchers aimed to determine whether tacrolimus as a rinse solution improves postoperative liver function, including alanine aminotransferase (ALT) levels, in liver transplantation.", "results_summary": "The study found that tacrolimus rinse did not significantly improve postoperative liver function, as measured by ALT, AST, or TBIL levels. The results were consistent even after sensitivity analysis excluding extended donor criteria livers.", "population_specificity": "Liver transplant recipients (70 transplants across 3 RCTs).", "effective_dosage": "Not specified", "study_duration": "Postoperative liver function assessed at days 1, 2, and 7.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:40:12.193110+00:00"}
{"study_id": 103776, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to evaluate the liver-specific and metabolic effects of microbiome-targeted therapies, including probiotics and synbiotics, on alanine aminotransferase (ALT) activity and other markers in individuals with NAFLD.", "results_summary": "Probiotics/synbiotics were associated with significant reductions in ALT activity and liver stiffness, as well as improved hepatic steatosis, though results showed heterogeneity. Probiotics, but not synbiotics, also reduced body mass index.", "population_specificity": "Individuals with nonalcoholic fatty liver disease (NAFLD).", "effective_dosage": "Not specified", "study_duration": "8 to 28 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:40:13.184282+00:00"}
{"study_id": 103779, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 85, "study_goal": "The study aimed to identify predictors of death in patients with yellow fever virus infection, including the role of alanine aminotransferase (ALT) levels as a potential biomarker.", "results_summary": "Higher alanine aminotransferase (ALT) levels at hospital admission were associated with increased mortality in yellow fever patients, suggesting its potential as a prognostic marker. The study did not evaluate alanine as a supplement or therapeutic agent.", "population_specificity": "Patients aged over 18 years admitted to hospitals in S\u00e3o Paulo, Brazil, during the 2018 yellow fever outbreak.", "effective_dosage": "Not applicable", "study_duration": "Not applicable", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:40:16.814289+00:00"}
{"study_id": 103778, "supplement_id": 863, "safety_score": "90", "efficacy_score": null, "quality_score": 85, "study_goal": "The researchers aimed to assess the safety profile of Enfuvirtide (T20) and Raltegravir (RAL) by evaluating markers of metabolic, mitochondrial, renal, and hepatic toxicity in healthy adult volunteers.", "results_summary": "The study found no statistically significant changes in markers of metabolic, mitochondrial, renal, or hepatic toxicity following short-term exposure to T20 or RAL, suggesting a safe profile for both drugs. No symptoms indicative of drug toxicity were observed in any participant.", "population_specificity": "Healthy adult volunteers", "effective_dosage": "T20/90mg or RAL/400mg every 12 hours", "study_duration": "Two 7-day periods separated by a 4-week washout", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:40:17.829139+00:00"}
{"study_id": 103780, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 75, "study_goal": "The researchers aimed to characterize the histopathology of chronic hepatitis E in immunosuppressed patients, including the role of alanine transaminase as a biochemical marker.", "results_summary": "The study found elevated alanine transaminase levels in immunosuppressed patients with chronic hepatitis E, alongside typical features of chronic hepatitis and destructive cholangitis in some cases.", "population_specificity": "Immunosuppressed patients (17 organ transplant recipients, 1 CD4-deficient, 1 on steroid therapy for ulcerative colitis).", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:40:18.262331+00:00"}
{"study_id": 103777, "supplement_id": 863, "safety_score": "70", "efficacy_score": 80, "quality_score": 85, "study_goal": "The researchers aimed to evaluate the safety, tolerability, pharmacokinetics, and efficacy of navoximod (GDC-0919), an IDO1 inhibitor, both as a monotherapy and in combination with atezolizumab in Japanese patients with advanced solid tumors.", "results_summary": "The study found that navoximod was well tolerated, with common adverse events including chromaturia and maculopapular rash. Stable disease was observed in 50% of monotherapy patients and 80% of combination therapy patients, suggesting potential efficacy.", "population_specificity": "Japanese patients with advanced solid tumors.", "effective_dosage": "200 mg, 400 mg, 600 mg, or 1000 mg orally twice daily (BID) for navoximod; 1200 mg intravenously every 21 days for atezolizumab in combination.", "study_duration": "Not specified in the abstract.", "interactions": "Combination with atezolizumab was studied, but no other interactions mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:40:18.883950+00:00"}
{"study_id": 103785, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to evaluate the effect of pegylated interferon maintenance therapy on liver inflammation, as indicated by alanine aminotransferase levels, in chronic hepatitis C patients who failed initial antiviral therapy.", "results_summary": "Maintenance therapy significantly improved alanine aminotransferase normalization compared to no treatment, but did not significantly affect hepatocellular carcinoma incidence or mortality rates.", "population_specificity": "Chronic hepatitis C patients who failed initial antiviral therapy (nonresponders or relapsers).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:40:20.183863+00:00"}
{"study_id": 103783, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 75, "study_goal": "The researchers were attempting to evaluate the pharmacokinetics of acetaminophen and changes in microRNA-122 levels when coadministered with Ojeok-san.", "results_summary": "The study found that coadministration of acetaminophen with Ojeok-san did not significantly alter the maximum plasma concentration of acetaminophen, with geometric mean ratios close to 1.", "population_specificity": "18 subjects in an open-label, crossover study.", "effective_dosage": "500 mg acetaminophen (3 times on day 1, once on day 2); 14.47 g Ojeok-san (twice on day 2, 3 times daily on days 3-7).", "study_duration": "9 days (including coadministration on days 8-9).", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:40:20.623169+00:00"}
{"study_id": 103781, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to compare the efficacy of ursodeoxycholic acid (UDCA) versus vitamin E plus vitamin C in improving alanine transaminase (ALT) levels, steatosis, and fibrosis in non-diabetic patients with nonalcoholic steatohepatitis (NASH).", "results_summary": "Vitamin E plus C combination significantly reduced mean ALT levels, steatosis score, and fibrosis score compared to UDCA after 12 months of treatment, suggesting it is an effective and safe option for NASH patients.", "population_specificity": "Non-diabetic patients with NASH, elevated aminotransferase levels, and alcohol consumption less than 40 g/week.", "effective_dosage": "Vitamin E 800 mg/day plus vitamin C 500 mg/day.", "study_duration": "12 months", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:40:20.828916+00:00"}
{"study_id": 103784, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 65, "study_goal": "The researchers aimed to diagnose and treat a case of neonatal cholestasis involving biliary atresia (BA) and progressive familial intrahepatic cholestasis type 3 (PFIC3), with elevated alanine aminotransferase as a biomarker.", "results_summary": "The study identified BA combined with PFIC3 in a 4-month-old female, treated with Kasai portoenterostomy and ursodeoxycholic acid, leading to symptom improvement and no recurrence over a 1-year follow-up. Alanine aminotransferase levels were elevated but not the focus of intervention or outcome assessment.", "population_specificity": "A 4-month-old female with neonatal cholestasis.", "effective_dosage": "Not specified", "study_duration": "1 year of follow-up", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:40:21.403756+00:00"}
{"study_id": 103787, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 65, "study_goal": "The researchers aimed to summarize clinical, biochemical, and genetic data of four new ALG3-CDG patients, a rare congenital disorder of glycosylation.", "results_summary": "The study identified four new ALG3-CDG patients through a type I pattern of serum transferrin and the accumulation of Man. No specific results regarding Alanine's effects were reported.", "population_specificity": "Patients with ALG3-CDG, a rare congenital disorder of glycosylation.", "effective_dosage": "Not available", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:40:25.139725+00:00"}
{"study_id": 103789, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to identify factors contributing to irisin increment after intensive exercise, including the role of alanine aminotransferase (ALT) in relation to irisin levels.", "results_summary": "The study found a positive and significant correlation between ALT and irisin levels, particularly with higher-intensity aerobic exercise. Linear regression confirmed an independent association between ALT and irisin, as well as between insulin and irisin.", "population_specificity": "38 sedentary young adult women without chronic diseases or regular medical treatments.", "effective_dosage": "Not specified", "study_duration": "2 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:40:26.377356+00:00"}
{"study_id": 103788, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": 50, "quality_score": 70, "study_goal": "The researchers aimed to explore the role of the Alanine-Glyoxylate Aminotransferase 2 (AGXT2)-dependent pathway in dimethylarginine metabolism and its potential influence on cardiovascular disease risk in Rheumatoid Arthritis (RA) patients.", "results_summary": "The study presents preliminary evidence that AGXT2 gene variants may affect dimethylarginine levels in RA patients, suggesting a possible link to endothelial dysfunction and atherosclerotic disease, but larger studies are needed to confirm these findings.", "population_specificity": "Rheumatoid Arthritis (RA) patients", "effective_dosage": "Not available", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:40:26.514124+00:00"}
{"study_id": 103786, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 85, "study_goal": "The researchers aimed to assess changes in serum biochemical and virological markers of HBV infection during and after pregnancy in women with chronic HBV, focusing on ALT flares.", "results_summary": "The study found that spontaneous ALT flares in untreated pregnant women with chronic HBV were infrequent, mild, and self-limited. Flares after withdrawal of antiviral therapy postpartum were more common but also mild and self-limited.", "population_specificity": "Pregnant women with chronic HBV infection in a North American cohort (median age 33 years, 73% Asian, 63% HBeAg-negative).", "effective_dosage": "Not specified", "study_duration": "Monitoring occurred during pregnancy (<28 weeks and >28 weeks of gestation) and postpartum (<16 weeks, 16-31 weeks, and 32-48 weeks).", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:40:27.226692+00:00"}
{"study_id": 103791, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the diagnostic accuracy of point-of-care alanine transaminase (ALT) testing performed by non-laboratory staff compared to conventional laboratory-based testing.", "results_summary": "The study found that point-of-care ALT testing by non-laboratory staff was comparable in diagnostic accuracy to conventional laboratory-based testing by professionals. The results suggest that task shifting of ALT testing is feasible and effective.", "population_specificity": "HIV patients in high-burden countries with limited access to laboratory diagnostics.", "effective_dosage": "Not available", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:40:28.164476+00:00"}
{"study_id": 103790, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 85, "study_goal": "The researchers aimed to evaluate the long-term safety and efficacy of ivacaftor in children aged 2 to 5 years with cystic fibrosis and a CFTR gating mutation, not specifically Alanine.", "results_summary": "The study found that ivacaftor was generally well tolerated for up to 108 weeks, with safety consistent with the initial KIWI study. Improvements in sweat chloride and growth parameters observed during the initial 24 weeks were maintained for an additional 84 weeks.", "population_specificity": "Children aged 2 to 5 years with cystic fibrosis and a CFTR gating mutation.", "effective_dosage": "Age- and weight-based ivacaftor dosages (specific amounts not provided).", "study_duration": "84 weeks (extension of a prior 24-week study).", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:40:29.504374+00:00"}
{"study_id": 103793, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 75, "study_goal": "The researchers aimed to describe the clinical presentation and treatment outcomes of patients with acute onset autoimmune hepatitis (AIH), focusing on biochemical markers including alanine transaminase (ALT).", "results_summary": "The study found elevated alanine transaminase (733\u00b1463.6) as a hallmark of acute AIH, alongside other biochemical markers. No specific biomarkers predicted remission, but advanced age was associated with poor prognosis.", "population_specificity": "Patients with acute onset autoimmune hepatitis (mean age 33.8\u00b11.5 years, 58.6% female).", "effective_dosage": "Not available", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:40:30.163925+00:00"}
{"study_id": 103792, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to determine whether combining telbivudine (LDT) with tenofovir disoproxil fumarate (TDF) could improve survival and renal outcomes in patients with spontaneous reactivation of chronic hepatitis B (SR-CHB), particularly those with acute-on-chronic liver failure (ACLF-B).", "results_summary": "The study found that combining LDT with TDF improved renal outcomes and survival in ACLF-B patients compared to TDF monotherapy, despite similar HBV DNA suppression. Patients on combination therapy showed significant improvement in acute kidney injury and less reduction in glomerular filtration rate.", "population_specificity": "Patients with spontaneous reactivation of chronic hepatitis B (SR-CHB), including those with acute-on-chronic liver failure (ACLF-B).", "effective_dosage": "TDF (300 mg/day) plus LDT (600 mg/day).", "study_duration": "12 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:40:30.378156+00:00"}
{"study_id": 103794, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": null, "study_goal": "The study does not address Alanine; it evaluates the safety and efficacy of idarubicin-eluting beads for transarterial chemoembolization in unresectable hepatocellular carcinoma.", "results_summary": "The study does not report findings related to Alanine.", "population_specificity": "Patients with unresectable hepatocellular carcinoma.", "effective_dosage": "Not mentioned (study focuses on idarubicin, not Alanine).", "study_duration": "Not mentioned (study focuses on idarubicin, not Alanine).", "interactions": "None mentioned (study focuses on idarubicin, not Alanine).", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:40:32.880210+00:00"}
{"study_id": 103795, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": null, "study_goal": "The study does not address Alanine; it evaluates the efficacy and safety of regorafenib for gastrointestinal stromal tumors (GISTs).", "results_summary": "The study found that regorafenib at a lower continuous dose achieved a disease control rate of 64% and a median progression-free survival of 7.3 months in GIST patients.", "population_specificity": "Patients with measurable, metastatic, or recurrent GISTs who failed imatinib and sunitinib.", "effective_dosage": "Regorafenib 100 mg orally daily.", "study_duration": "Not specified in the abstract.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:40:34.521664+00:00"}
{"study_id": 103798, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to determine whether pinitol supplementation could modulate oxidative stress and improve metabolic pathways involving alanine/aspartate/glutamate metabolism in NAFLD subjects.", "results_summary": "Pinitol supplementation significantly reduced liver fat content, oxidative stress markers, and improved glutathione-related lipid and energy metabolism, including pathways involving alanine.", "population_specificity": "90 subjects with ultrasonography-proven NAFLD.", "effective_dosage": "Low-dose (300 mg/d) and high-dose (500 mg/d).", "study_duration": "12 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:40:35.516624+00:00"}
{"study_id": 103796, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 75, "study_goal": "The study aimed to compare the effectiveness of TACE plus HIFU versus TACE alone in treating primary liver cancer, with liver function markers (including ALT) as secondary outcomes.", "results_summary": "The study found no statistical difference in ALT levels between the TACE plus HIFU and TACE-alone groups, suggesting no significant impact on alanine aminotransferase. The combined treatment showed higher remission rates and lower recurrence/metastasis rates.", "population_specificity": "90 primary liver cancer patients in China.", "effective_dosage": "Not specified for Alanine (ALT was measured as a marker, not administered).", "study_duration": "Treatment and follow-up spanned from March 2015 to March 2017 (exact intervention duration not specified).", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:40:35.812613+00:00"}
{"study_id": 103797, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to investigate the association between genetic variants in the vitamin D metabolic pathway and the response to Peg-IFN therapy, including ALT normalization, in HBeAg-negative chronic HBV patients.", "results_summary": "The study found that the GC rs222020 TT genotype was associated with higher odds of ALT normalization (OR=4.61) and HBsAg seroclearance after Peg-IFN therapy. Baseline HBsAg levels and this genetic variant independently predicted treatment response.", "population_specificity": "HBeAg-negative chronic HBV patients, predominantly infected with HBV genotype C (83.7%), including some with compensated liver cirrhosis (8.7%).", "effective_dosage": "Not specified (Peg-IFN therapy duration was 48 weeks).", "study_duration": "48 weeks of Peg-IFN therapy, with follow-up at 24 weeks post-treatment.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:40:37.466676+00:00"}
{"study_id": 103801, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 88, "study_goal": "The researchers aimed to determine the effect of probiotics/synbiotics on alanine aminotransferase levels and other parameters in NAFLD patients.", "results_summary": "The study found that probiotics/synbiotics significantly improved alanine aminotransferase and aspartate aminotransferase levels, reduced high-sensitivity C-reactive protein, and improved liver fibrosis scores in NAFLD patients.", "population_specificity": "Patients with nonalcoholic fatty liver disease (NAFLD).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:40:38.079533+00:00"}
{"study_id": 103799, "supplement_id": 863, "safety_score": "40", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to evaluate the safety and efficacy of tagraxofusp (a CD123-directed cytotoxin) in treating untreated or relapsed BPDCN, with a focus on clinical responses and adverse events, including hepatic dysfunction marked by increased alanine aminotransferase levels.", "results_summary": "The study found that tagraxofusp led to clinical responses in 72% of previously untreated patients, but adverse events like increased alanine aminotransferase (64%) and capillary leak syndrome (19%) were common. Hepatic dysfunction and thrombocytopenia were frequent side effects.", "population_specificity": "Adult patients (median age 70) with untreated or relapsed blastic plasmacytoid dendritic-cell neoplasm (BPDCN).", "effective_dosage": "7 \u03bcg or 12 \u03bcg per kilogram of body weight on days 1 to 5 of each 21-day cycle.", "study_duration": "Treatment continued until disease progression or unacceptable toxic effects (median follow-up not specified).", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:40:41.033610+00:00"}
{"study_id": 103800, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to compare the hepatoprotective effects of Oxy, Res, and MulA on acute liver injury induced by LPS/d-GalN in mice, focusing on Alanine transaminase (ALT) levels.", "results_summary": "Treatment with Oxy, Res, and MulA significantly reduced ALT and AST levels, with MulA being the most effective (90.3% and 93.9% reduction, respectively). The stilbenes also curbed inflammation and oxidative stress by modulating NF-\u03baB, MAPK, and Nrf2 pathways.", "population_specificity": "Mice with acute liver injury induced by LPS/d-GalN.", "effective_dosage": "80 mg/kg body weight/day (intragastric administration).", "study_duration": "7 hours post-exposure to LPS/d-GalN.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:40:41.151899+00:00"}
{"study_id": 103802, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 75, "study_goal": "The researchers aimed to review the epidemiology, causes, and clinical significance of elevated liver transaminases, particularly alanine aminotransferase, in HIV-infected patients.", "results_summary": "The abstract highlights that elevated liver transaminases, including alanine aminotransferase, are common in HIV patients and associated with liver-related mortality. It also notes that serum fibrosis biomarkers based on these enzymes predict all-cause mortality.", "population_specificity": "HIV-infected individuals, particularly those with risk factors for liver damage (e.g., hepatitis coinfection, alcohol abuse, ART hepatotoxicity).", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:40:41.514017+00:00"}
{"study_id": 103803, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 65, "study_goal": "The researchers aimed to evaluate the biochemical changes, including alanine transaminase (ALT) levels, in children with Duchenne muscular dystrophy (DMD) after repeated cycles of G-CSF therapy.", "results_summary": "The study found a significant decrease in alanine transaminase (ALT) activity following G-CSF treatment, alongside reductions in cholesterol and glucose levels, suggesting potential metabolic benefits for DMD patients.", "population_specificity": "Nineteen children aged 5-15 years with genetically confirmed DMD, including both wheelchair-bound and mobile patients.", "effective_dosage": "G-CSF (5 \u03bcg/kg/day) administered in cycles (exact frequency not specified).", "study_duration": "Each cycle lasted five days (total number of cycles not specified).", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:40:44.090873+00:00"}
{"study_id": 103804, "supplement_id": 863, "safety_score": "30", "efficacy_score": 20, "quality_score": 85, "study_goal": "The researchers aimed to evaluate whether standard-dose paracetamol in dengue infection caused transaminase elevation (including alanine transaminase, ALT) and to assess its efficacy as an antipyretic.", "results_summary": "The study found that standard-dose paracetamol increased the incidence of transaminase elevation (22% vs. 10% in placebo) and raised overall ALT concentrations without reducing fever or pain scores. No liver failure occurred, but severe dengue complications were noted in the paracetamol group.", "population_specificity": "Adult participants (\u226518 years) with confirmed dengue infection in Thailand.", "effective_dosage": "500 mg every 4 hours when body temperature exceeded 38\u00b0C (median daily dose: 1.5 g).", "study_duration": "During hospitalization (exact duration not specified).", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:40:45.523615+00:00"}
{"study_id": 103805, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to evaluate the effect of hepatic impairment on the pharmacokinetics of alisertib, an investigational anticancer agent, in patients with advanced solid tumors or lymphoma.", "results_summary": "Alisertib exposure was higher in patients with moderate or severe hepatic impairment compared to those with normal hepatic function, leading to a recommendation for a 60% dose reduction in impaired patients. Protein binding of alisertib was approximately 99% across all groups.", "population_specificity": "Adult patients with advanced solid tumors or lymphoma, categorized by hepatic function (normal, moderate impairment, severe impairment).", "effective_dosage": "Single 50-mg oral dose initially; continued dosing at 50, 30, or 10 mg twice daily for normal, moderate, and severe hepatic impairment, respectively.", "study_duration": "Blood samples collected up to 168 hours postdose; continued dosing in 21-day cycles.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:40:48.825190+00:00"}
{"study_id": 103806, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the association between antineoplastic treatment for childhood cancer and hepatic late adverse effects, including cellular liver injury indicated by elevated alanine aminotransferase (ALT).", "results_summary": "The prevalence of hepatic late adverse effects, particularly elevated ALT, varied widely (5.8% to 52.8%). Risk factors included radiotherapy involving the liver, higher BMI, chronic viral hepatitis, and longer follow-up time.", "population_specificity": "Long-term childhood cancer survivors (aged 18 years or less at diagnosis).", "effective_dosage": "Not specified", "study_duration": "Follow-up durations varied from 3 to 23 years post-cancer diagnosis.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:40:49.008204+00:00"}
{"study_id": 103807, "supplement_id": 863, "safety_score": "85", "efficacy_score": 90, "quality_score": 92, "study_goal": "The researchers aimed to assess the efficacy, resistance, and safety of tenofovir disoproxil fumarate (TDF) in Chinese patients with chronic HBV infection over 240 weeks.", "results_summary": "TDF demonstrated sustained viral suppression without resistance development, with virological suppression rates exceeding 84% in both HBeAg-positive and HBeAg-negative patients. Alanine transaminase levels normalized in most patients, and safety profiles were comparable between TDF-TDF and ADV-TDF groups.", "population_specificity": "Chinese patients with chronic hepatitis B virus (HBV) infection (HBeAg-positive or HBeAg-negative).", "effective_dosage": "TDF 300 mg once daily.", "study_duration": "240 weeks (48-week double-blind phase followed by 192-week open-label phase).", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:40:49.747041+00:00"}
{"study_id": 103810, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the efficacy and safety of telbivudine (LdT) and tenofovir (TDF) in preventing HBV vertical transmission in HBV-positive pregnant women, with a focus on alanine aminotransferase (ALT) levels as a marker.", "results_summary": "The study found that both LdT and TDF significantly reduced HBV DNA levels compared to no treatment, with no difference in ALT levels among groups. Infants of treated mothers had significantly lower HBsAg positivity rates (0% for LdT and TDF vs. 11.1% for untreated).", "population_specificity": "HBV-positive pregnant women with HBV DNA \u22651.0 \u00d7 10^6 copies/mL and elevated ALT levels.", "effective_dosage": "Not specified in the abstract.", "study_duration": "From enrollment (January 2013 to June 2017) until delivery, with infant follow-up at 6 and 12 months postpartum.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:40:54.297295+00:00"}
{"study_id": 103811, "supplement_id": 863, "safety_score": "85", "efficacy_score": 60, "quality_score": 90, "study_goal": "The researchers aimed to evaluate the safety and efficacy of GS-4774, a yeast-based therapeutic vaccine for chronic HBV infection, in combination with tenofovir disoproxil fumarate (TDF), focusing on immune response and viral antigen reduction.", "results_summary": "GS-4774 was safe and well-tolerated but did not significantly reduce HBsAg levels. It increased production of IFNG, TNF, and IL2 in HBV-specific CD8+ T cells, with minimal effects on CD4+ T cells.", "population_specificity": "Adults with chronic HBV infection (HBsAg-positive >6 months, HBV DNA \u22652000 IU/mL), untreated for HBV within 3 months prior.", "effective_dosage": "2, 10, or 40 yeast units GS-4774, administered subcutaneously every 4 weeks for 6 doses.", "study_duration": "20 weeks (total of 6 doses).", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:40:56.639048+00:00"}
{"study_id": 103814, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 85, "study_goal": "The researchers aimed to investigate associations between metabolites, including Alanine, and BMI z-score, height, weight, HOMA, and lipoprotein concentrations in pre-pubertal children.", "results_summary": "The abstract does not specifically mention Alanine's effects, focusing instead on sphingomyelin (SM) 32:2 as the metabolite most strongly associated with BMI z-score.", "population_specificity": "Pre-pubertal children from three European studies (n=1,020).", "effective_dosage": "Not available", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:40:56.792380+00:00"}
{"study_id": 103812, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to evaluate the effectiveness of metformin, silymarin, pioglitazone, and vitamin E in improving liver aminotransferases (including alanine transaminase) in patients with NAFLD.", "results_summary": "The study found that silymarin, pioglitazone, and vitamin E significantly reduced liver enzymes (including alanine transaminase) in NAFLD patients after 3 months, with no specific side effects reported. The control group showed no significant change in these enzymes.", "population_specificity": "150 patients with NAFLD (47.0\u00b19.1 years, 48.7% women, 51.3% men).", "effective_dosage": "Not specified for alanine; interventions included metformin 500 mg/day, silymarin 140 mg/day, pioglitazone 15 mg/day, and vitamin E 400 IU/day.", "study_duration": "3 months", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:40:56.997332+00:00"}
{"study_id": 103815, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 75, "study_goal": "The study aimed to evaluate the effectiveness and safety of unfractionated heparin as an anticoagulation agent after digital replantation, not specifically focused on Alanine.", "results_summary": "The study found no significant differences among the heparin dosage groups except for complications of congestion. Elevated alanine aminotransferase levels were noted in the high-dose heparin group by day 7.", "population_specificity": "Patients (88 total, 101 fingers) who underwent digital amputation and subsequent repair by anastomosis of both arteries and veins.", "effective_dosage": "Not applicable (study focused on heparin, not Alanine).", "study_duration": "Outcomes assessed at 2 weeks post-replantation.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:40:58.245129+00:00"}
{"study_id": 103813, "supplement_id": 863, "safety_score": "45", "efficacy_score": 30, "quality_score": 75, "study_goal": "The researchers evaluated the safety, tolerability, pharmacokinetics, and pharmacodynamics of AMG 172, an anti-CD27L antibody-drug conjugate, in patients with relapsed/refractory clear cell renal cell carcinoma (ccRCC).", "results_summary": "The study identified 1.6 mg/kg as the maximum tolerated dose, with common adverse events including thrombocytopenia, nausea, and liver injury. Limited antitumor activity was observed, with only 5.4% of patients showing a partial response.", "population_specificity": "Patients with relapsed/refractory clear cell renal cell carcinoma (ccRCC).", "effective_dosage": "0.15, 0.3, 0.6, 1.2, 1.6, 1.8, and 2.4 mg/kg on a biweekly dosing schedule.", "study_duration": "Not specified in the abstract.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:40:58.292656+00:00"}
{"study_id": 103809, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 85, "study_goal": "The study aimed to compare clinical outcomes (e.g., stent dysfunction, survival) between unilateral and bilateral metal stenting in patients with malignant hilar biliary obstruction (MHO), noting the role of pre-operative alanine aminotransferase levels as a predictor of survival.", "results_summary": "The study found no significant difference in clinical effectiveness between unilateral and bilateral stenting for MHO. Higher pre-operative alanine aminotransferase levels were associated with worse survival outcomes.", "population_specificity": "Patients with malignant hilar biliary obstruction (MHO).", "effective_dosage": "Not available", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:41:01.980315+00:00"}
{"study_id": 103808, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 75, "study_goal": "The study aimed to compare the characteristics and outcomes of elderly patients (>65 years) with Mediterranean spotted fever (MSF) to younger adults, focusing on clinical manifestations and treatment response.", "results_summary": "The study found that severe MSF was more frequent in elderly patients, with specific symptoms like raised alanine transaminase occurring more often. Single-day doxycycline therapy was effective and well-tolerated in elderly patients, with recovery times similar to younger adults.", "population_specificity": "Elderly patients (>65 years) and younger adults with confirmed MSF.", "effective_dosage": "Two oral doses of 200 mg doxycycline for 1 day.", "study_duration": "1 day", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:41:02.944318+00:00"}
{"study_id": 103818, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the effects of late evening snacks (LES) containing Alanine on liver function in patients with cirrhosis.", "results_summary": "LES intervention improved liver function reserve, showing significant effects on albumin, ammonia, prothrombin time, and liver enzymes (AST and ALT), and reduced complications like ascites and hepatic encephalopathy.", "population_specificity": "Patients with liver cirrhosis, with or without hepatocellular carcinoma.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:41:03.663915+00:00"}
{"study_id": 103816, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 75, "study_goal": "The study aimed to investigate the safety and efficacy of pralatrexate, not Alanine, in Chinese patients with relapsed/refractory peripheral T-cell lymphoma (PTCL).", "results_summary": "The study found pralatrexate had an overall response rate of 52% in Chinese patients with R/R PTCL, with common adverse events including stomatitis, anemia, and alanine aminotransferase increase. No results specific to Alanine were reported.", "population_specificity": "Chinese patients with relapsed/refractory peripheral T-cell lymphoma (PTCL).", "effective_dosage": "Pralatrexate IV 30 mg/m\u00b2 (not Alanine).", "study_duration": "Not specified for Alanine.", "interactions": "None mentioned for Alanine.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:41:04.355341+00:00"}
{"study_id": 103819, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 75, "study_goal": "The researchers aimed to compare the pharmacokinetic profiles of UDCA and its conjugates (G-UDCA and T-UDCA) between healthy elderly subjects and younger adults, and assess safety markers including alanine aminotransferase levels.", "results_summary": "The study found that dose-normalized peak concentration and systemic exposure to UDCA were 2-4 times higher in elderly subjects compared to younger adults, with G-UDCA and T-UDCA levels 1.7 times higher. Alanine aminotransferase levels remained within normal ranges in elderly subjects after multiple UDCA administrations.", "population_specificity": "16 elderly subjects and 16 younger adults.", "effective_dosage": "400 or 800 mg UDCA on day 1, followed by 200 mg twice daily for 2 weeks.", "study_duration": "2 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:41:06.735617+00:00"}
{"study_id": 103821, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to compare the effects of a meal replacement regimen (soy protein-based) versus a guided lifestyle intervention on liver fat content and markers of hepatic inflammation, including alanine transaminase (ALT), in NASH patients.", "results_summary": "Both the meal replacement and lifestyle intervention groups showed comparable reductions in body and liver fat, as well as decreased markers of hepatic inflammation (e.g., ALT).", "population_specificity": "Twenty-six subjects with non-alcoholic steatohepatitis (NASH).", "effective_dosage": "Not specified (meal replacement included soy-yogurt-honey preparation).", "study_duration": "24 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:41:07.734626+00:00"}
{"study_id": 103820, "supplement_id": 863, "safety_score": "70", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to assess the safety and identify the recommended phase 2 dose of the PARP inhibitor olaparib in combination with the PI3K inhibitor alpelisib, including evaluating adverse effects such as increased alanine aminotransferase concentrations.", "results_summary": "The study found that increased alanine aminotransferase concentrations were a common treatment-related grade 3-4 adverse event (9% of patients). The combination therapy showed preliminary clinical evidence of synergism, particularly in epithelial ovarian cancer.", "population_specificity": "Patients aged 18 years or older with recurrent ovarian, fallopian tube, primary peritoneal cancer, or breast cancer, including those with germline BRCA mutations.", "effective_dosage": "Various doses of alpelisib (200-300 mg once daily) and olaparib (100-200 mg twice daily) were tested.", "study_duration": "Not specified in the abstract.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:41:07.795857+00:00"}
{"study_id": 103817, "supplement_id": 863, "safety_score": "65", "efficacy_score": 70, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the safety, pharmacologic activity, and clinical efficacy of epacadostat (an IDO1 inhibitor) in combination with ipilimumab for advanced melanoma, including its impact on alanine aminotransferase levels.", "results_summary": "The study found that epacadostat combined with ipilimumab showed clinical activity (26% objective response rate in immunotherapy-naive patients) but was associated with adverse events, including alanine aminotransferase elevation (28%). Dose-limiting toxicities occurred at higher doses, but \u226450 mg BID was generally well tolerated.", "population_specificity": "Patients with advanced melanoma (n=50), including both immunotherapy-naive (n=39) and prior immunotherapy recipients (n=11).", "effective_dosage": "25, 50, 100, or 300 mg twice daily (BID); 75 mg daily (50 mg AM, 25 mg PM); or 50 mg BID intermittent (2 weeks on/1 week off).", "study_duration": "Not explicitly stated, but treatment was administered until discontinuation (primarily due to adverse events or disease progression).", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:41:08.946821+00:00"}
{"study_id": 103822, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": 20, "quality_score": 75, "study_goal": "The researchers aimed to validate MARCKSL1 protein expression as a prognostic marker for distant metastasis-free survival in lymph-node negative breast cancer patients.", "results_summary": "MARCKSL1 expression did not show significant prognostic value for distant metastasis-free survival in this cohort. Only tumor diameter among classical prognosticators demonstrated prognostic significance.", "population_specificity": "151 operable T1,2N0M0 lymph-node negative breast cancer patients", "effective_dosage": "Not available", "study_duration": "Median follow-up time was 152 months (range 11-189 months)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:41:10.302342+00:00"}
{"study_id": 103823, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 85, "study_goal": "The study aimed to assess the safety and efficacy of a multi-targeted antiviral regimen (including OBV/PTV/r + DSV \u00b1 SOF with or without RBV) in DAA treatment-experienced adults with chronic HCV GT1 infection, not specifically focused on Alanine.", "results_summary": "The study found high SVR12 rates (95.5% in part 1, 85.7% in part 2) with the regimen, but two patients experienced grade 3 elevations of serum alanine aminotransferase, indicating potential liver-related adverse effects.", "population_specificity": "Adults with chronic HCV GT1 infection who had prior treatment failure to any DAA or ledipasvir/SOF.", "effective_dosage": "Not specified for Alanine.", "study_duration": "12 or 24 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:41:13.390212+00:00"}
{"study_id": 103824, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 75, "study_goal": "The researchers aimed to compare the safety and efficacy of an abbreviated 12-hour acetylcysteine regimen versus a standard 20-hour regimen for treating paracetamol overdose, using miR-122 as a biomarker for liver injury.", "results_summary": "The study found no significant difference in liver injury markers (ALT and miR-122) between the abbreviated and standard acetylcysteine regimens, suggesting the abbreviated regimen is safe for low-risk paracetamol overdose patients.", "population_specificity": "Patients treated for paracetamol poisoning (38 patients, 121 blood samples).", "effective_dosage": "Abbreviated regimen (200 mg/kg over 4 h, 50 mg/kg over 8 h); standard regimen (200 mg/kg over 4 h, 100 mg/kg over 16 h).", "study_duration": "12 hours (abbreviated) or 20 hours (standard).", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:41:14.273070+00:00"}
{"study_id": 103825, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 75, "study_goal": "The study aimed to evaluate the safety and efficacy of surufatinib, a small-molecule inhibitor, in patients with advanced neuroendocrine tumors (NETs), including its impact on alanine aminotransferase levels as an adverse event.", "results_summary": "The study found that surufatinib showed encouraging antitumor activity in advanced NETs, with increased alanine aminotransferase (5%) as one of the common grade \u22653 treatment-related adverse events. Disease control rates were high in both pancreatic (91%) and extrapancreatic (92%) NET cohorts.", "population_specificity": "Patients with histologically well-differentiated, low or intermittent grade, inoperable or metastatic neuroendocrine tumors (NETs).", "effective_dosage": "300 mg orally, once daily.", "study_duration": "Not specified in the abstract.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:41:14.844001+00:00"}
